adzenys xr-odt (amphetamine er) 3.1 mg oral …...adzenys xr-odt (amphetamine er) 6.3 mg oral...
TRANSCRIPT
Quantity Limit Program Summary
Program Target Drugs Dosage/StrengthQuantity Limit
(Units/Day or as noted)
5HT-1F PAQL ** 5HT-1F QL information is included in the individual program document
ADHD PS AR0320_r0520
Adderall (amphetamine/dextroamphetamine) 5 mg tableta 2 tablets
Adderall (amphetamine/dextroamphetamine) 7.5 mg tableta 2 tablets
Adderall (amphetamine/dextroamphetamine) 10 mg tableta 2 tablets
Adderall (amphetamine/dextroamphetamine) 12.5 mg tableta 2 tablets
Adderall (amphetamine/dextroamphetamine) 15 mg tableta 2 tablets
Adderall (amphetamine/dextroamphetamine) 20 mg tableta 3 tablets
Adderall (amphetamine/dextroamphetamine) 30 mg tableta 2 tablets
Adderall XR (amphetamine/dextroamphetamine extended-release)5 mg capsulea 1 capsule
Adderall XR (amphetamine/dextroamphetamine extended-release)10 mg capsulea 1 capsule
Adderall XR (amphetamine/dextroamphetamine extended-release)15 mg capsulea 1 capsule
Adderall XR (amphetamine/dextroamphetamine extended-release)20 mg capsulea 1 capsule
Adderall XR (amphetamine/dextroamphetamine extended-release)25 mg capsulea 1 capsule
Adderall XR (amphetamine/dextroamphetamine extended-release)30 mg capsulea 1 capsule
Adhansia XR (methylphenidate ER) 25 mg capsule 1 capsuleAdhansia XR (methylphenidate ER) 35 mg capsule 1 capsuleAdhansia XR (methylphenidate ER) 45 mg capsule 1 capsuleAdhansia XR (methylphenidate ER) 55 mg capsule 1 capsuleAdhansia XR (methylphenidate ER) 70 mg capsule 1 capsuleAdhansia XR (methylphenidate ER) 85 mg capsule 1 capsule
Adzenys ER (amphetamine ER), Amphetamine ER suspension1.25 mg/1 mL solution 15 mL
Adzenys XR-ODT (amphetamine ER) 3.1 mg oral disintegrating tablet 2 tablets
Adzenys XR-ODT (amphetamine ER) 6.3 mg oral disintegrating tablet 2 tablets
Adzenys XR-ODT (amphetamine ER) 9.4 mg oral disintegrating tablet 1 tablet
Adzenys XR-ODT (amphetamine ER) 12.5 mg oral disintegrating tablet 1 tablet
Adzenys XR-ODT (amphetamine ER) 15.7 mg oral disintegrating tablet 1 tablet
Adzenys XR-ODT (amphetamine ER) 18.8 mg oral disintegrating tablet 1 tablet
Aptensio XR, Methylphenidate ER capsule 10 mg capsule 1 capsule
Aptensio XR, Methylphenidate ER capsule 15 mg capsule 1 capsule
Quantity limits apply to Medicaid.
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 1
Minnesota Medicaid Quantity Limit Program Criteria
Aptensio XR, Methylphenidate ER capsule 20 mg capsule 1 capsule
Aptensio XR, Methylphenidate ER capsule 30 mg capsule 1 capsule
Aptensio XR, Methylphenidate ER capsule 40 mg capsule 1 capsule
Aptensio XR, Methylphenidate ER capsule 50 mg capsule 1 capsule
Aptensio XR, Methylphenidate ER capsule 60 mg capsule 1 capsule
Cotempla XR ODT (methylphenidate ER orally dissolving tablet)8.6 mg orally disintegrating tablet 1 tablet
Cotempla XR ODT (methylphenidate ER orally dissolving tablet)17.3 mg orally disintegrating tablet 2 tablets
Cotempla XR ODT (methylphenidate ER orally dissolving tablet)25.9 mg orally disintegrating tablet 2 tablets
Concerta (methylphenidate extended-release) 18 mg tableta 1 tablet
Concerta (methylphenidate extended-release) 27 mg tableta 1 tablet
Concerta (methylphenidate extended-release) 36 mg tableta 2 tablets
Concerta (methylphenidate extended-release) 54 mg tableta 1 tablet
Daytrana (methylphenidate transdermal patch)10 mg/9 hr patch 1 patch
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 2
Minnesota Medicaid Quantity Limit Program Criteria
Daytrana (methylphenidate transdermal patch)15 mg/9 hr patch 1 patchDaytrana (methylphenidate transdermal patch)20 mg/9 hr patch 1 patchDaytrana (methylphenidate transdermal patch)30 mg/9 hr patch 1 patch
Desoxyn (methamphetamine) 5 mg tablet 5 tablets
dextroamphetamine 5 mg tableta 3 tablets
dextroamphetamine 10 mg tableta 6 tablets
Dexedrine (dextroamphetamine extended-release)
5 mg extended-release
capsulea
3 capsules
Dexedrine (dextroamphetamine extended-release)
10 mg extended-release
capsulea
4 capsules
Dexedrine (dextroamphetamine extended-release)
15 mg extended-release
capsulea
4 capsules
Dyanavel XR (amphetamine ER suspension)2.5 mg / mL 8 mL
Evekeo (amphetamine) 5 mg tableta 3 tablets
Evekeo (amphetamine) 10 mg tableta 6 tablets
Evekeo ODT (amphetamine)
5 mg orally disintegrating
tablet2 tablets
Evekeo ODT (amphetamine)
10 mg orally
disintegrating tablet2 tablets
Evekeo ODT (amphetamine)
15 mg orally
disintegrating tablet2 tablets
Evekeo ODT (amphetamine)
20 mg orally
disintegrating tablet2 tablets
ADHD PS AR0320_r0520
Focalin (dexmethylphenidate) 2.5 mg tableta 2 tablets
Focalin (dexmethylphenidate) 5 mg tableta 2 tablets
Focalin (dexmethylphenidate) 10 mg tableta 2 tablets
Focalin XR (dexmethylphenidate extended-release)5 mg capsulea 1 capsule
Focalin XR (dexmethylphenidate extended-release)10 mg capsulea 1 capsule
Focalin XR (dexmethylphenidate extended-release)15 mg capsulea 1 capsule
Focalin XR (dexmethylphenidate extended-release)20 mg capsulea 1 capsule
Focalin XR (dexmethylphenidate extended-release)25 mg capsulea 1 capsule
Focalin XR (dexmethylphenidate extended-release)30 mg capsulea 1 capsule
Focalin XR (dexmethylphenidate extended-release)35 mg capsulea 1 capsule
Focalin XR (dexmethylphenidate extended-release)40 mg capsulea 1 capsule
Intuniv (guanfacine extended-release)
1 mg extended-release
tableta
1 tablet
Intuniv (guanfacine extended-release)
2 mg extended-release
tableta
1 tablet
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 3
Minnesota Medicaid Quantity Limit Program Criteria
Intuniv (guanfacine extended-release)
3 mg extended-release
tableta
1 tablet
Intuniv (guanfacine extended-release)
4 mg extended-release
tableta
1 tablet
Jornay PM (methylphenidate extended-release)20 mg ER capsule 1 capsuleJornay PM (methylphenidate extended-release)40 mg ER capsule 1 capsuleJornay PM (methylphenidate extended-release)60 mg ER capsule 1 capsuleJornay PM (methylphenidate extended-release)80 mg ER capsule 1 capsuleJornay PM (methylphenidate extended-release)100 mg ER capsule 1 capsule
Kapvay (clonidine extended-release)
0.1 mg extended-release
tableta
4 tabletsa
Metadate CD (methylphenidate extended-release)10 mg capsulea 1 capsule
Metadate CD (methylphenidate extended-release)20 mg capsulea 1 capsule
Metadate CD (methylphenidate extended-release)30 mg capsulea 1 capsule
Metadate CD (methylphenidate extended-release)40 mg capsulea 1 capsule
Metadate CD (methylphenidate extended-release)50 mg capsulea 1 capsule
Metadate CD (methylphenidate extended-release)60 mg capsulea 1 capsule
Metadate ER (methylphenidate extended-release)20 mg tableta 3 tablets
Methylin (methylphenidate) 2.5 mg chewable tableta
3 tablets
Methylin (methylphenidate) 5 mg chewable tableta 3 tablets
Methylin (methylphenidate) 10 mg chewable tableta
6 tablets
Methylin (methylphenidate) 5 mg/5 mL solutiona 15 mL
Methylin (methylphenidate) 10 mg/5 mL solutiona 30 mL
Methylin ER (methylphenidate extended-release)10 mg tableta 3 tablets
Methylin ER (methylphenidate extended-release)20 mg tableta 3 tablets
methylphenidate ER 18 mg tablet 1 tablet
methylphenidate ER 27 mg tablet 1 tablet
methylphenidate ER 36 mg tablet 2 tablets
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 4
Minnesota Medicaid Quantity Limit Program Criteria
methylphenidate ER 54 mg tablet 1 tablet
methylphenidate ER 72 mg tablet 1 tablet
Mydayis 12.5 mg capsule 1 capsule
Mydayis 25 mg capsule 1 capsule
Mydayis 37.5 mg capsule 1 capsule
Mydayis 50 mg capsule 1 capsule
Procentra (dextroamphetamine oral solution) 5 mg/5 mL oral solutiona
60 mL
Quillichew (methylphenidate ER chewable)20 mg 1 tablet
Quillichew (methylphenidate ER chewable)30 mg 2 tablets
Quillichew (methylphenidate ER chewable)40 mg 1 tablet
Quillivant XR (methylphenidate) 25 mg/5 ml oral
suspension
12 mL
Relexxii (methylphenidate ER) 72 mg tablet 1 tablet
Ritalin (methylphenidate) 5 mg tableta 3 tablets
Ritalin (methylphenidate) 10 mg tableta 3 tablets
Ritalin (methylphenidate) 20 mg tableta 3 tablets
Ritalin LA (methylphenidate extended–release) 10 mg capsulea 1 capsule
Ritalin LA (methylphenidate extended–release) 20 mg capsulea 1 capsule
Ritalin LA (methylphenidate extended–release) 30 mg capsulea 1 capsule
Ritalin LA (methylphenidate extended–release) 40 mg capsulea 1 capsule
Ritalin LA (methylphenidate extended–release) 60 mg capsulea 1 capsule
ADHD PS AR0320_r0520
Strattera (atomoxetine) 10 mg capsulea 2 capsules
Strattera (atomoxetine) 18 mg capsulea 2 capsules
Strattera (atomoxetine) 25 mg capsulea 2 capsules
Strattera (atomoxetine) 40 mg capsulea 2 capsules
Strattera (atomoxetine) 60 mg capsulea 1 capsule
Strattera (atomoxetine) 80 mg capsulea 1 capsule
Strattera (atomoxetine) 100 mg capsulea 1 capsule
Vyvanse (lisdexamfetamine) 10 mg capsule 1 capsuleVyvanse (lisdexamfetamine) 20 mg capsule 1 capsuleVyvanse (lisdexamfetamine) 30 mg capsule 1 capsuleVyvanse (lisdexamfetamine) 40 mg capsule 1 capsuleVyvanse (lisdexamfetamine) 50 mg capsule 1 capsuleVyvanse (lisdexamfetamine) 60 mg capsule 1 capsuleVyvanse (lisdexamfetamine) 70 mg capsule 1 capsule
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 5
Minnesota Medicaid Quantity Limit Program Criteria
Vyvanse chewable (lisdexamfetamine) 10 mg chewable tablet 1 tablet
Vyvanse chewable (lisdexamfetamine) 20 mg chewable tablet 1 tablet
Vyvanse chewable (lisdexamfetamine) 30 mg chewable tablet 1 tablet
Vyvanse chewable (lisdexamfetamine) 40 mg chewable tablet 1 tablet
Vyvanse chewable (lisdexamfetamine) 50 mg chewable tablet 1 tablet
Vyvanse chewable (lisdexamfetamine) 60 mg chewable tablet 1 tablet
Zenzedi (dextroamphetamine) 2.5 mg tablet 3 tabletsZenzedi (dextroamphetamine) 7.5 mg tablet 3 tabletsZenzedi (dextroamphetamine) 15 mg tablet 3 tabletsZenzedi (dextroamphetamine) 20 mg tablet 3 tabletsZenzedi (dextroamphetamine) 30 mg tablet 2 tablets
Alinia QL ** Alinia QL information is included in the individual program document
Ampyra PAQL ** Ampyra QL information is included in the individual program document
Androgens_Anabolic
Steroids PAQL ** Androgen_Anabolic Steroid QL information is included in the individual program document
Anticoagulant QL ** Anticoagulant QL information is included in the individual program document
Antidepressants PS AR0320
Selective Serotonin Reuptake Inhibitors
(SSRIs)
Celexa (citalopram)a 10 mg tablet 1 tablet
Celexa (citalopram)a 20 mg tablet 1 tablet
Celexa (citalopram)a 40 mg tablet 1 tablet
Celexa (citalopram)a 10 mg/5 mL oral solution 20 mL
Lexapro (escitalopram)a 5 mg tablet 1 tablet
Lexapro (escitalopram)a 10 mg tablet 1 tablet
Lexapro (escitalopram)a 20 mg tablet 1 tablet
Lexapro (escitalopram)a 5 mg/5 mL oral solution 20 mL
fluvoxamine ERa 100 mg extended-release
capsule
2 capsules
fluvoxamine ERa 150 mg extended-release
capsule
2 capsules
fluvoxaminea 25 mg tablet 1 tablet
fluvoxaminea 50 mg tablet 1 tablet
a - available as a generic, included in quantity limit program
Quantity limits apply to Medicaid.
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 6
Minnesota Medicaid Quantity Limit Program Criteria
fluvoxaminea 100 mg tablet 3 tablets
Paxil (paroxetine)a 10 mg tablet 1 tablet
Paxil (paroxetine)a 20 mg tablet 1 tablet
Paxil (paroxetine)a 30 mg tablet 2 tablets
Paxil (paroxetine)a 40 mg tablet 1 tablet
Paxil (paroxetine) 10 mg/5 mL suspension 30 mL
Paxil CR (paroxetine ER)a 12.5 mg controlled-
release tablet
1 tablet
Paxil CR (paroxetine ER)a 25 mg controlled-release
tablet
2 tablets
Paxil CR (paroxetine ER)a 37.5 mg controlled-
release tablet
2 tablets
Pexeva (paroxetine) 10 mg tablet 1 tabletPexeva (paroxetine) 20 mg tablet 1 tabletPexeva (paroxetine) 30 mg tablet 2 tabletsPexeva (paroxetine) 40 mg tablet 1 tablet
Prozac (fluoxetine)a 10 mg capsule 1 capsule
Prozac (fluoxetine)a 20 mg capsule 4 capsules
Prozac (fluoxetine)a 40 mg capsule 2 capsules
Prozac (fluoxetine)a 10 mg tablet 1 tablet
Prozac (fluoxetine)a 20 mg tablet 4 tablets
Prozac, (fluoxetine)a 60 mg tablet 1 tablet
Prozac (fluoxetine)a 20 mg/5 mL oral solution 20 mL
Prozac Weekly (fluoxetine) 90 mg delayed-release
capsule
4 capsules/28 days
Zoloft (sertraline)a 25 mg tablet 1 tablet
Zoloft (sertraline)a 50 mg tablet 1 tablet
Zoloft (sertraline)a 100 mg tablet 2 tablets
Zoloft (sertraline)a 20 mg/mL oral
concentrate
10 mL
Serotonin Norepinephrine Reuptake
Inhibitors (SNRIs)
Cymbalta (duloxetine)a 20 mg delayed-release
capsule
2 capsules
Cymbalta (duloxetine)a 30 mg delayed-release
capsule
2 capsules
Cymbalta (duloxetine)a 60 mg delayed-release
capsule
2 capsules
Desvenlafaxine 50 mg extended-release
tablet 1 tablet
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 7
Minnesota Medicaid Quantity Limit Program Criteria
Desvenlafaxine 100 mg extended-release
tablet
1 tablet
Desvenlafaxine fumarate 50 mg extended-release
tablet 1 tablet
Desvenlafaxine fumarate 100 mg extended-release
tablet
1 tablet
Drizalma Sprinkle 20 mg delayed release
sprinkle capsule
2 capsules
Drizalma Sprinkle 30 mg delayed release
sprinkle capsule
2 capsules
Drizalma Sprinkle 40 mg delayed release
sprinkle capsule
2 capsules
Drizalma Sprinkle 60 mg delayed release
sprinkle capsule
2 capsules
Effexor (venlafaxine)a 25 mg tablet 3 tablets
Effexor (venlafaxine)a 37.5 mg tablet 3 tablets
Effexor (venlafaxine)a 50 mg tablet 3 tablets
Effexor (venlafaxine)a 75 mg tablet 3 tablets
Effexor (venlafaxine)a 100 mg tablet 3 tablets
Effexor XR (venlafaxine ER)a 37.5 mg extended-
release capsule 1 capsule
Effexor XR (venlafaxine ER)a 75 mg extended-release
capsule
3 capsules
Effexor XR (venlafaxine ER)a 150 mg extended-release
capsule
1 capsule
Fetzima (levomilnacipran) 20 mg extended-release
capsule 1 capsule
Fetzima (levomilnacipran) 40 mg extended-release
capsule 1 capsule
Fetzima (levomilnacipran) 80 mg extended-release
capsule 1 capsule
Fetzima (levomilnacipran) 120 mg extended-release
capsule 1 capsule
Fetzima (levomilnacipran) Titration pack (2 x 20
mg, 26 x 40 mg) 1 kit (28 capsules)/28 days
Khedezla (desvenlafaxine) 50 mg extended-release
tablet 1 tablet
Khedezla (desvenlafaxine) 100 mg extended-release
tablet
1 tablet
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 8
Minnesota Medicaid Quantity Limit Program Criteria
duloxetinea 40 mg delayed release
capsule
3 capsules
Antidepressants PS AR0320
Venlafaxine ERa 37.5 mg extended-
release tablet 1 tablet
Venlafaxine ERa 75 mg extended-release
tablet
3 tablets
Venlafaxine ERa 150 mg extended-release
tablet
1 tablet
Venlafaxine ERa 225 mg extended-release
tablet
1 tablet
Pristiq (desvenlafaxine)a 25 mg extended-release
tablet1 tablet
Pristiq (desvenlafaxine)a 50 mg extended-release
tablet 1 tablet
Pristiq (desvenlafaxine)a 100 mg extended-release
tablet
1 tablet
Other AntidepressantsAplenzin (bupropion) 174 mg extended-release
tablet
1 tablet
Aplenzin (bupropion) 348 mg extended-release
tablet
1 tablet
Aplenzin (bupropion) 522 mg extended-release
tablet
1 tablet
Forfivo XL (bupropion)
a 450 mg extended-release
tablet
1 tablet
Maprotiline 25 mg tablet 3 tabletsMaprotiline 50 mg tablet 3 tabletsMaprotiline 75 mg tablet 3 tablets
Remeron (mirtazapine)a
7.5 mg tabletf 1 tablet
Remeron (mirtazapine)a 15 mg tablet 1 tablet
Remeron (mirtazapine)a 30 mg tablet 1 tablet
Remeron (mirtazapine)a 45 mg tablet 1 tablet
Remeron SolTab (mirtazapine)a
15 mg orally-
disintegrating tablet
1 tablet
Remeron SolTab (mirtazapine)a
30 mg orally-
disintegrating tablet
1 tablet
Remeron SolTab (mirtazapine)a
45 mg orally-
disintegrating tablet
1 tablet
Trintellix (vortioxetine) 5 mg tablet 1 tabletTrintellix (vortioxetine) 10 mg tablet 1 tabletTrintellix (vortioxetine) 20 mg tablet 1 tablet
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 9
Minnesota Medicaid Quantity Limit Program Criteria
Viibryd (vilazodone) 10 mg tablet 1 tabletViibryd (vilazodone) 20 mg tablet 1 tabletViibryd (vilazodone) 40 mg tablet 1 tabletViibryd (vilazodone) Starter Kit (7 x 10mg, 23
x 20mg)
1 kit/180 days
Wellbutrin (bupropion)a 75 mg tablet 2 tablets
Wellbutrin (bupropion)a 100 mg tablet 4 tablets
Wellbutrin SR, Budeprion SR (bupropion SR)a
100 mg sustained-release
tablet
2 tablets
Wellbutrin SR, Budeprion SR (bupropion SR)a
150 mg sustained-release
tablet
2 tablets
Wellbutrin SR, Budeprion SR (bupropion SR)a
200 mg sustained-release
tabletd
2 tablets
Wellbutrin XL, Budeprion XL (bupropion ER)a
150 mg extended-release
tablet
1 tablet
Wellbutrin XL, Budeprion XL (bupropion ER)a
300 mg extended-release
tablet
1 tablet
a - available as a generic, included in quantity limit program
Antiemetic QL ** Antiemetic QL information is included in the individual program document
Antipsychotics, Atypical PS
AR0320Abilify (aripiprazole)
a 2 mg tablet 1 tablet
Abilify (aripiprazole)a 5 mg tablet 1 tablet
Abilify (aripiprazole)a 10 mg tablet 1 tablet
Abilify (aripiprazole)a 15 mg tablet 1 tablet
Abilify (aripiprazole)a 20 mg tablet 1 tablet
Abilify (aripiprazole)a 30 mg tablet 1 tablet
aripiprazole 1 mg/mL oral solution 30 mL
aripiprazole 10 mg orally
disintegrating tablet
2 tablets
aripiprazole 15 mg orally
disintegrating tablet
2 tablets
Abilify Maintena (aripiprazole) 300 mg extended-release
prefilled syringe
1 syringe/28 days
Abilify Maintena (aripiprazole) 300 mg vial extended-
release injection
1 vial/28 days
Abilify Maintena (aripiprazole) 400 mg extended-release
prefilled syringe
1 syringe/28 days
Abilify Maintena (aripiprazole) 400 mg vial extended-
release injection
1 vial/28 days
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 10
Minnesota Medicaid Quantity Limit Program Criteria
Abilify Mycite (aripiprazole with sensor) 2 mg tablet 1 tabletAbilify Mycite (aripiprazole with sensor) 5 mg tablet 1 tabletAbilify Mycite (aripiprazole with sensor) 10 mg tablet 1 tabletAbilify Mycite (aripiprazole with sensor) 15 mg tablet 1 tabletAbilify Mycite (aripiprazole with sensor) 20 mg tablet 1 tabletAbilify Mycite (aripiprazole with sensor) 30 mg tablet 1 tablet
Aristada (aripiprazole lauroxil injection) 441 mg injection 0.0534 mLAristada (aripiprazole lauroxil injection) 662 mg injection 0.08 mLAristada (aripiprazole lauroxil injection) 882 mg injection 0.1067 mLAristada (aripiprazole lauroxil injection) 1064 mg injection 0.0697 mLAristada Initio (aripiprazole lauroxil extended-
release injection)
675 mg injection 1 syringe/180 days
Caplyta (lumataperone) 42 mg capsule 1 capsule
Clozaril (clozapine)a 25 mg, tablet 3 tablets
Clozaril (clozapine)a 50 mg tablet 3 tablets
Clozaril (clozapine)a 100 mg tablet 9 tablets
Clozaril (clozapine)a 200 mg tablet 4 tablets
Fanapt (iloperidone) 1 mg tablet 2 tabletsFanapt (iloperidone) 2 mg tablet 2 tabletsFanapt (iloperidone) 4 mg tablet 2 tabletsFanapt (iloperidone) 6 mg tablet 2 tabletsFanapt (iloperidone) 8 mg tablet 2 tabletsFanapt (iloperidone) 10 mg tablet 2 tabletsFanapt (iloperidone) 12 mg tablet 2 tabletsFanapt (iloperidone) Titration pak 1 pak (8 tablets)/180 days
FazaClo (clozapine) 12.5 mg orally
disintegrating tableta,c
3 tablets
FazaClo (clozapine)a 25 mg orally
disintegrating tablet
9 tablets
FazaClo (clozapine)a 100 mg orally
disintegrating tablet
3 tablets
FazaClo (clozapine) 150 mg orally
disintegrating tablet
6 tablets
FazaClo (clozapine) 200 mg orally
disintegrating tablet
4 tablets
Geodon (ziprasidone)a 20 mg capsule 2 capsules
Geodon (ziprasidone)a 40 mg capsule 2 capsules
Geodon (ziprasidone)a 60 mg capsule 2 capsules
Geodon (ziprasidone)a 80 mg capsule 2 capsules
Geodon (ziprasidone)a 20 mg/mL injection 2 vials
Invega (paliperidone)a 1.5 mg tablet 1 tablet
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 11
Minnesota Medicaid Quantity Limit Program Criteria
Invega (paliperidone)a 3 mg tablet 1 tablet
Invega (paliperidone)a 6 mg tablet 2 tablets
Invega (paliperidone)a 9 mg tablet 1 tablet
Invega Sustenna (paliperidone)39 mg/kit extended-
release injection
1 kit/28 days
Invega Sustenna (paliperidone)78 mg/kit extended-
release injection
1 kit/28 days
Invega Sustenna (paliperidone)117 mg/kit extended-
release injection
1 kit/28 days
Invega Sustenna (paliperidone)156 mg/kit extended-
release injection
1 kit/28 days
Invega Sustenna (paliperidone)234 mg/kit extended-
release injection
1 kit/28 days
Invega Trinza (paliperidone) 273 mg / 0.875 mL 0.875 mL / 90 daysAntipsychotics, Atypical PS
AR0320 Invega Trinza (paliperidone)410 mg / 1.315 mL 1.315 mL / 90 days
Invega Trinza (paliperidone) 546 mg / 1.75 mL 1.75 mL / 90 daysInvega Trinza (paliperidone) 819 mg / 2.625 mL 2.625 mL / 90 days
Latuda (lurasidone) 20 mg tablet 1 tabletLatuda (lurasidone) 40 mg tablet 1 tabletLatuda (lurasidone) 60 mg tablet 1 tabletLatuda (lurasidone) 80 mg tablet 2 tabletLatuda (lurasidone) 120 mg tablet 1 tablet
Perseris (risperidone)90 mg kit extended-
release injection
1 kit/30 days
Perseris (risperidone)120 mg kit extended-
release injection
1 kit/30 days
Rexulti (brexpiprazole) 0.25 mg tablet 1 tablet
Rexulti (brexpiprazole) 0.5 mg tablet 1 tablet
Rexulti (brexpiprazole) 1 mg tablet 1 tablet
Rexulti (brexpiprazole) 2 mg tablet 1 tablet
Rexulti (brexpiprazole) 3 mg tablet 1 tablet
Rexulti (brexpiprazole) 4 mg tablet 1 tablet
Risperdal (risperidone)a 0.25 mg tablet 2 tablets
Risperdal (risperidone)a 0.5 mg tablet 2 tablets
Risperdal (risperidone)a 1 mg tablet 2 tablets
Risperdal (risperidone)a 2 mg tablet 2 tablets
Risperdal (risperidone)a 3 mg tablet 2 tablets
Risperdal (risperidone)a 4 mg tablet 4 tablets
Risperdal (risperidone)a 1 mg/mL oral solution 16 mL
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 12
Minnesota Medicaid Quantity Limit Program Criteria
risperidone0.25 mg orally
disintegrating tablet
2 tablets
Risperdal M-Tab (risperidone)a
0.5 mg orally
disintegrating tablet
2 tablets
Risperdal M-Tab (risperidone)a
1 mg orally disintegrating
tablet
2 tablets
risperidone2 mg orally disintegrating
tablet
2 tablets
Risperdal M-Tab (risperidone)a
3 mg orally disintegrating
tablet
2 tablets
Risperdal M-Tab (risperidone)a
4 mg orally disintegrating
tablet
4 tablets
Risperdal Consta (risperidone)12.5 mg/vial long-acting
injection
2 vials/28 days
Risperdal Consta (risperidone)25 mg/vial long-acting
injection
2 vials/28 days
Risperdal Consta (risperidone)37.5 mg/vial long-acting
injection
2 vials/28 days
Risperdal Consta (risperidone)50 mg/vial long-acting
injection
2 vials/28 days
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 13
Minnesota Medicaid Quantity Limit Program Criteria
Saphris (asenapine)2.5 mg sublingual tablet 2 tablets
Saphris (asenapine) 5 mg sublingual tablet 2 tablets
Saphris (asenapine)10 mg sublingual tablet 2 tablets
Secuado (asenapine)3.8 mg/ 24hr
transdermal patch
1 patch
Secuado (asenapine)5.7 mg/ 24hr
transdermal patch
1 patch
Secuado (asenapine)7.6 mg/ 24hr
transdermal patch
1 patch
Seroquel (quetiapine)a 25 mg tablet 3 tablets
Seroquel (quetiapine)a 50 mg tablet 3 tablets
Seroquel (quetiapine)a 100 mg tablet 3 tablets
Seroquel (quetiapine)a 200 mg tablet 3 tablets
Seroquel (quetiapine)a 300 mg tablet 2 tablets
Seroquel (quetiapine)a 400 mg tablet 2 tablets
Antipsychotics, Atypical PS
AR0320
Seroquel XR (quetiapine)a
50 mg extended-release
tablet
2 tablets
Seroquel XR (quetiapine)a
150 mg extended-release
tablet
1 tablet
Seroquel XR (quetiapine)a
200 mg extended-release
tablet
1 tablet
Seroquel XR (quetiapine)a
300 mg extended-release
tablet
2 tablets
Seroquel XR (quetiapine)a
400 mg extended-release
tablet
2 tablets
Versacloz (clozapine)50 mg/ml oral
suspension
18 mL
Vraylar (cariprazine) 1.5 mg capsule 1 capsule
Vraylar (cariprazine) 3 mg capsule 1 capsule
Vraylar (cariprazine) 4.5 mg capsule 1 capsule
Vraylar (cariprazine) 6 mg capsule 1 capsule
Vraylar (cariprazine) Titration Therapy Pack 1 pack / 180 days
Zyprexa (olanzapine)a 2.5 mg tablet 1 tablet
Zyprexa (olanzapine)a 5 mg tablet 1 tablet
Zyprexa (olanzapine)a 7.5 mg tablet 1 tablet
Zyprexa (olanzapine)a 10 mg tablet 1 tablet
Zyprexa (olanzapine)a 15 mg tablet 1 tablet
Zyprexa (olanzapine)a 20 mg tablet 1 tablet
Zyprexa (olanzapine)a 10 mg/vial injection 3 vials
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 14
Minnesota Medicaid Quantity Limit Program Criteria
Zyprexa Zydis (olanzapine)a
5 mg orally disintegrating
tablet
1 tablet
Zyprexa Zydis (olanzapine)a
10 mg orally
disintegrating tablet
1 tablet
Zyprexa Zydis (olanzapine)a
15 mg orally
disintegrating tablet
1 tablet
Zyprexa Zydis (olanzapine)a
20 mg orally
disintegrating tablet
1 tablet
Zyprexa Relprevv (olanzapine)210 mg vial extended-
release injection
2 vials/28 days
Zyprexa Relprevv (olanzapine)300 mg vial extended-
release injection
2 vials/28 days
Zyprexa Relprevv (olanzapine)405 mg vial extended-
release injection
1 vial/28 days
Antiretroviral PS
AR0819_r0420
Aptivus (tipranavir)
100 mg/mL (95 mL
bottle) oral solution 12.6667 mL (380 mL/30 days)b
Aptivus (tipranavir) 250 mg capsule 4 capsules
Atripla (efavirenz/emtricitabine/ tenofovir)
600 mg/200 mg/300 mg
tablet 1 tablet
Biktarvy (bictegravir, emtricitabine, tenofovir)
50 mg/200 mg/25 mg
tablet 1 tablet
Cimduo, Temixys (lamivudine/tenofovir) 300 mg/300 mg tablet 1 tablet
Combivir (lamivudine/zidovudine) 150 mg/300 mg tableta
2 tablets
Complera (emtricitabine/rilpivirine/tenofovir)
200 mg/25 mg/300 mg
tablet 1 tablet
Crixivan (indinavir) 200 mg capsule 9 capsulesCrixivan (indinavir) 400 mg capsule 6 capsules
Delstrigo (doravirine/lamivudine/tenofovir) 100 mg/300 mg/300 mg 1 tablet
Descovy (emtricitabine/tenofovir) 200 mg/25 mg tablet 1 tablet
Dovato (dolutegravir/lamivudine) 50 mg / 300 mg tablet 1 tablet
Edurant (rilpivirine) 25 mg tablet 1 tablet
a - generic available and included in the program; b – available only as
Quantity limits apply to Medicaid.
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 15
Minnesota Medicaid Quantity Limit Program Criteria
Emtriva (emtracitabine) 10 mg/mL oral soluion 24.2856 mL (680 mL/28 days)Emtriva (emtracitabine) 200 mg capsule 1 capsule
Epivir (lamivudine)
10 mg/mL oral soluion
(240 mL bottle)a
32 mL (960 mL/30 days)b
Epivir (lamivudine) 150 mg tableta
2 tablets
Epivir (lamivudine) 300 mg tableta
1 tablet
Epzicom (lamivudine/abacavir) 600 mg/300 mg tableta
1 tablet
Evotaz (atazanavir/cobicistat) 300 mg/150 mg tablet 1 tablet
Fuzeon (enfuvirtide)
108 mg/vial (to deliver
90 mg/mL dose) 2 vials (60 vials/month)
Genvoya
(elvitegravir/cobicistat/emtricitabine/ten
ofovir)
150 mg/150 mg/200 mg/ 10 mg tablet
1 tablet
Intelence (etravirine) 25 mg tablet 4 tabletsIntelence (etravirine) 100 mg tablet 2 tabletsIntelence (etravirine) 200 mg tablet 2 tablets
Invirase (saquinavir mesylate) 200 mg capsule 10 capsulesInvirase (saquinavir mesylate) 500 mg tablet 4 tablets
Isentress (raltegravir) 25 mg chewable tablets6 tablets
Isentress (raltegravir) 100 mg chewable tablets 6 tabletsIsentress (raltegravir) 400 mg tablets 2 tablets
Isentress (raltegravir)
100 mg packet for
suspension 2 packetsIsentress HD (raltegravir) 600 mg tablets 2 tablets
Juluca (dolutegravir/rilpivirine) 50 mg/25 mg tablets 1 tablet
Kaletra (lopinavir/ritonavir)
80 mg/20 mg per mL
(160 mL bottle oral soln)a
16 mL (480 mLs/30 days)b
Kaletra (lopinavir/ritonavir) 100 mg/25 mg tablet 6 tabletsKaletra (lopinavir/ritonavir) 200 mg/50 mg tablet 4 tablets
Lexiva (fosamprenavir)
50 mg/mL (225 mL
bottle) oral suspension 60 mL (1800 mL/30 days)b
Lexiva (fosamprenavir) 700 mg tableta
4 tablets
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 16
Minnesota Medicaid Quantity Limit Program Criteria
Norvir (ritonavir)
80 mg/mL (240 mL
bottle) oral solution 16 mL (480 mL/30 days)b
Norvir (ritonavir) 100 mg capsule 12 capsules
Norvir (ritonavir) 100 mg tableta
12 tablets
Norvir (ritonavir) 100 mg powder packet 12 packets
Odefsey (emtricitabine/rilpivirine/tenofovir)200 mg/25 mg/25 mg 1 tablet
Pifeltro (doravirine) 100 mg 1 tablet
Prezcobix (darunavir/cobicistat) 800 mg/150 mg tablet 1 tablet
Antiretroviral PS
AR0819_r0420 Prezista (darunavir) 100 mg/mL suspension 13.3334 mL (400 mL/30 days)b
Prezista (darunavir) 75 mg tablet 10 tabletsPrezista (darunavir) 150 mg tablet 6 tabletsPrezista (darunavir) 600 mg tablet 2 tabletsPrezista (darunavir) 800 mg tablet 1 tablet
Rescriptor (delavridine) 100 mg tablet 12 tabletsRescriptor (delavridine) 200 mg tablet 6 tablets
Reyataz (atazanavir) 150 mg capsulea
1 capsule
Reyataz (atazanavir) 200 mg capsulea
2 capsules
Reyataz (atazanavir) 300 mg capsulea
1 capsuleReyataz (atazanavir) 50 mg powder packet 8 packets
Selzentry (maraviroc) 25 mg tablet 8 tablets
Selzentry (maraviroc) 75 mg tablet 2 tablets
Selzentry (maraviroc) 150 mg tablet 2 tabletsSelzentry (maraviroc) 300 mg tablet 4 tablets
Selzentry (maraviroc) 20 mg/mL oral solution 61.334 mL (1840 mL/30 days)
Stribild
(elvitegravir/cobistat/emtricitabine/tenofovir)
150 mg/150 mg/200
mg/300mg 1 tablet
Sustiva (efavirenz) 50 mg capsulea
3 capsules
Sustiva (efavirenz) 200 mg capsulea
2 capsules
Sustiva (efavirenz) 600 mg tableta 1 tablet
Symfi (efavirenz/lamivudine/tenofovir) 600 mg/300 mg/300mg 1 tablet
Symfi Lo (efavirenz/lamivudine/tenofovir) 400 mg/300 mg/300mg 1 tablet
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 17
Minnesota Medicaid Quantity Limit Program Criteria
Symtuza
(darunavir/cobicistat/emtricitabine/tenofovir)
800 mg/150 mg/200
mg/10 mg 1 tablet
Tivicay (dolutegravir) 10 mg tablet 2 tablets
Tivicay (dolutegravir) 25 mg tablet 2 tabletsTivicay (dolutegravir) 50 mg tablet 2 tablets
Triumeq (abacavir/dolutegravir/lamivudine)600 mg/50 mg/300 mg
tablet 1 tablet
Trizivir (abacavir, lamivudine, zidovudine)
300 mg/150 mg/300 mg
tableta
2 tablets
Truvada (emtracitabine/tenofovir) 100/150 mg tablet 1 tablet
Truvada (emtracitabine/tenofovir) 133/200 mg tablet 1 tablet
Truvada (emtracitabine/tenofovir) 167/250 mg tablet 1 tabletTruvada (emtracitabine/tenofovir) 200 mg/300 mg tablet 1 tablet
Tybost (cobicistat) 150 mg tablet 1 tablet
Videx (didanosine)
2 g powder (10 mg/mL in
100 mL bottle) 40 mL (1200 mL/30 days)b
Videx (didanosine)
4 g powder (10 mg/mL in
200 mL bottle) 40 mL (1200 mL/30 days)Videx EC (didanosine) 125 mg capsule 1 capsuleVidex EC (didanosine) 200 mg capsule 1 capsuleVidex EC (didanosine) 250 mg capsule 1 capsule
Videx EC (didanosine) 400 mg capsulea 1 capsule
Viracept (nelfinavir) 250 mg tablet 9 tabletsViracept (nelfinavir) 625 mg tablet 4 tablets
Viramune (nevirapine)
50 mg/5 mL suspension
(240 mL bottle)a
40 mL (1200 mL/30 days)
Viramune (nevirapine) 200 mg tableta 2 tablets
Viramune XR (nevirapine)
100 mg extended-release
tableta 3 tablets
Viramune XR (nevirapine)
400 mg extended-release
tableta 1 tablet
Viread (tenofovir) 150 mg tablet 1 tabletViread (tenofovir) 200 mg tablet 1 tabletViread (tenofovir) 250 mg tablet 1 tablet
Viread (tenofovir) 300 mg tableta
1 tablet
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 18
Minnesota Medicaid Quantity Limit Program Criteria
Viread (tenofovir)
40 mg/1g oral powder for
reconstitution (60 g can) 8 g (240 g/30 days)b
Vitekta (elvitegravir) 85 mg tablet 1 tabletVitekta (elvitegravir) 150 mg tablet 1 tablet
Zerit (stavudine)
1 mg/mL oral solution
(200 mL bottle) 80 mL (2400 mL/30 days)
Zerit (stavudine) 15 mg capsulea
2 capsules
Zerit (stavudine) 20 mg capsulea
2 capsules
Zerit (stavudine) 30 mg capsulea
2 capsules
Zerit (stavudine) 40 mg capsulea
2 capsules
Antiretroviral PS
AR0819_r0420Ziagen (abacavir)
20 mg/mL oral solution
(240 mL bottle)a
32 mL (960 mL/30 days)b
Ziagen (abacavir) 300 mg tableta
2 tablets
zidovudine
50 mg/5 mL syrup (10
mg/mL in 240 mL bottle) 64 mL (1920 mL/30 days)b
zidovudine 100 mg capsulea
6 capsules
zidovudine 300 mg tableta
2 tablets
ARB/Renin Inhibitors PS AR0819_r0320 Angiotensin II Receptor Antagonists (ARBs), ARB Combinations
Atacand (candesartan)a 4 mg tablets 2 tablets
Atacand (candesartan)a 8 mg tablets 2 tablets
Atacand (candesartan)a 16 mg tablets 2 tablets
Atacand (candesartan)a 32 mg tablets 1 tablet
Atacand HCT
(candesartan/hydrochlorothiazide)a
16 mg/12.5 mg tablets 1 tabletAtacand HCT
(candesartan/hydrochlorothiazide)a
32 mg/12.5 mg tablets 1 tabletAtacand HCT
(candesartan/hydrochlorothiazide)a
32 mg/25 mg tablets 1 tablet
ARB/Renin Inhibitors PS
AR0819_r0320Avapro (irbesartan)
a 75 mg tablets 1 tablet
Avapro (irbesartan)a 150 mg tablets 1 tablet
Avapro (irbesartan)a 300 mg tablets 1 tablet
Avalide (irbesartan/hydrochlorothiazide)a 150 mg/12.5 mg tablets 1 tablet
Quantity limits apply to Medicaid.
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 19
Minnesota Medicaid Quantity Limit Program Criteria
Avalide (irbesartan/hydrochlorothiazide)a 300 mg/12.5 mg tablets 1 tablet
Azor (amlodipine/olmesartan medoxomil)a 5 mg/20 mg tablets 1 tablet
Azor (amlodipine/olmesartan medoxomil)a 5 mg/40 mg tablets 1 tablet
Azor (amlodipine/olmesartan medoxomil)a 10 mg/20 mg tablets 1 tablet
Azor (amlodipine/olmesartan medoxomil)a 10 mg/40 mg tablets 1 tablet
Benicar (olmesartan)a 5 mg tablets 2 tablets
Benicar (olmesartan)a 20 mg tablets 1 tablet
Benicar (olmesartan)a 40 mg tablets 1 tablet
Benicar HCT
(olmesartan/hydrochlorothiazide)a
20 mg/12.5 mg tablets 1 tablet
Benicar HCT
(olmesartan/hydrochlorothiazide)a
40 mg/12.5 mg tablets 1 tablet
Benicar HCT
(olmesartan/hydrochlorothiazide)a
40 mg/25 mg tablets 1 tablet
Byvalson (nebivolol/valsartan) 5 mg/80 mg tablets 1 tablet
Cozaar (losartan)a 25 mg tablets 2 tablets
Cozaar (losartan)a 50 mg tablets 2 tablets
Cozaar (losartan)a 100 mg tablets 1 tablet
Diovan (valsartan)a 40 mg tablets 2 tablets
Diovan (valsartan)a 80 mg tablets 2 tablets
Diovan (valsartan)a 160 mg tablets 2 tablets
Diovan (valsartan)a 320 mg tablets 1 tablet
Diovan HCT (valsartan/hydrochlorothiazide)a
80 mg/12.5 mg tablets 1 tablet
Diovan HCT (valsartan/hydrochlorothiazide)a
160 mg/12.5 mg tablets 1 tablet
Diovan HCT (valsartan/hydrochlorothiazide)a
160 mg/25 mg tablets 1 tablet
Diovan HCT (valsartan/hydrochlorothiazide)a
320 mg/12.5 mg tablets 1 tablet
Diovan HCT (valsartan/hydrochlorothiazide)a
320 mg/25 mg tablets 1 tablet
Edarbi (azilsartan) 40 mg tablets 1 tabletEdarbi (azilsartan) 80 mg tablets 1 tablet
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 20
Minnesota Medicaid Quantity Limit Program Criteria
Edarbyclor (azilsartan/chlorthalidone) 40 mg/12.5 mg tablets 1 tablet
Edarbyclor (azilsartan/chlorthalidone) 40 mg/25 mg tablets 1 tablet
Exforge (amlodipine/valsartan) 5 mg/160 mg tablets 1 tabletExforge (amlodipine/valsartan) 5 mg/320 mg tablets 1 tabletExforge (amlodipine/valsartan) 10 mg/160 mg tablets 1 tabletExforge (amlodipine/valsartan) 10 mg/320 mg tablets 1 tablet
Exforge HCT
(amlodipine/valsartan/hydrochlorothiazide)a 5 mg/160 mg/12.5 mg
tablets 1 tablet
Exforge HCT
(amlodipine/valsartan/hydrochlorothiazide)a 5 mg/160 mg/25 mg
tablets 1 tablet
Exforge HCT
(amlodipine/valsartan/hydrochlorothiazide)a 10 mg/160 mg/12.5 mg
tablets 1 tablet
Exforge HCT
(amlodipine/valsartan/hydrochlorothiazide)s 10 mg/160 mg/25 mg
tablets 1 tablet
Exforge HCT
(amlodipine/valsartan/hydrochlorothiazide)s 10 mg/320 mg/25 mg
tablets 1 tablet
Hyzaar (losartan/hydrochlorothiazide)a 50 mg/12.5 mg tablets 1 tablet
Hyzaar (losartan/hydrochlorothiazide)a 100 mg/12.5 mg tablets 1 tablet
Hyzaar (losartan/hydrochlorothiazide)a 100 mg/25 mg tablets 1 tablet
Micardis (telmisartan)a 20 mg tablets 1 tablet
Micardis (telmisartan)a 40 mg tablets 1 tablet
Micardis (telmisartan)a 80 mg tablets 1 tablet
Micardis HCT
(telmisartan/hydrochlorothiazide)a
40 mg/12.5 mg tablets 1 tablet
Micardis HCT
(telmisartan/hydrochlorothiazide)a
80 mg/12.5 mg tablets 2 tablets
Micardis HCT
(telmisartan/hydrochlorothiazide)a
80 mg/25 mg tablets 1 tablet
Teveten (eprosartan) 400 mg tablets 2 tabletsTeveten, Eprosartan 600 mg tablets 1 tablet
Tribenzor
(olmesartan/amlodipine/hydrochlorothiazide)a 20 mg/5 mg/12.5 mg
tablets 1 tablet
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 21
Minnesota Medicaid Quantity Limit Program Criteria
Tribenzor
(olmesartan/amlodipine/hydrochlorothiazide)a 40 mg/5 mg/12.5 mg
tablets 1 tablet
Tribenzor
(olmesartan/amlodipine/hydrochlorothiazide)a 40 mg/5 mg/25 mg
tablets 1 tablet
Tribenzor
(olmesartan/amlodipine/hydrochlorothiazide)a 40 mg/10 mg/12.5 mg
tablets 1 tablet
Tribenzor
(olmesartan/amlodipine/hydrochlorothiazide)a 40 mg/10 mg/25 mg
tablets 1 tablet
Twynsta (telmisartan/amlodipine)a 40 mg/5 mg tablets 1 tablet
Twynsta (telmisartan/amlodipine)a 40 mg/10 mg tablets 1 tablet
Twynsta (telmisartan/amlodipine)a 80 mg/5 mg tablets 1 tablet
Twynsta (telmisartan/amlodipine)a 80 mg/10 mg tablets 1 tablet
Renin Inhibitors, Renin Inhibitor Combinations
Tekturna (aliskiren)a 150 mg tablets 1 tablet
Tekturna (aliskiren)a 300 mg tablets 1 tablet
Tekturna HCT (aliskiren/hydrochlorothiazide) 150 mg/12.5 mg tablets 1 tablet
Tekturna HCT (aliskiren/hydrochlorothiazide) 150 mg/25 mg tablets 1 tablet
Tekturna HCT (aliskiren/hydrochlorothiazide) 300 mg/12.5 mg tablets 1 tablet
Tekturna HCT (aliskiren/hydrochlorothiazide) 300 mg/25 mg tablets 1 tablet
Arikayce PAQL
ATTR Amyloidosis PAQL
Baclofen PS 0120_r0320Ozobax (baclofen) 5 mg/5 mL oral solution 2400 mL/30 days
Benign Prostatic
Hypertrophy (BPH) PS
AR0819_r0320
Alpha Blockers (Selective)Flomax (tamsulosin) 0.4 mg capsules
a 2 capsules
Rapaflo (silodosin) 4 mg capsulesa 1 capsule
Rapaflo (silodosin) 8 mg capsulesa 1 capsule
Quantity limits apply to Medicaid.
**Arikayce QL information is included in the individual program document
Quantity limits apply to Medicaid.
** ATTR Amyloidosis QL information is included in the individual program document
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 22
Minnesota Medicaid Quantity Limit Program Criteria
Uroxatral (alfuzosin) 10 mg extended-release
tabletsa
1 tablet
Alpha Blockers (Nonselective)Cardura (doxazosin) 1 mg tablets
a 1 tablet
Cardura (doxazosin) 2 mg tabletsa 1 tablet
Cardura (doxazosin) 4 mg tabletsa 1 tablet
Cardura (doxazosin) 8 mg tabletsa 2 tablets
Cardura XL (doxazosin) 4 mg extended-release
tablets
1 tablet
Cardura XL (doxazosin) 8 mg extended-release
tablets
1 tablet
terazosin 1 mg capsulesa 1 capsule
terazosin 2 mg capsulesa 1 capsule
terazosin 5 mg capsulesa 1 capsule
terazosin 10 mg capsulesa 2 capsules
Alpha Reductase InhibitorsAvodart (dutasteride) 0.5 mg capsules
a 1 capsule
Proscar (finasteride) 5 mg tabletsa 1 tablet
Alpha Reductase Inhibitor/Alpha Blocker
CombinationsJalyn (dutasteride/tamsulosin) 0.5 mg/0.4 mg capsules
a 1 capsule
BenzodiazepinesCS AR0520 Xanax (alprazolam) 0.25 mg tablets 4 tablets
Xanax (alprazolam) 0.5 mg tablets 4 tablets
Xanax (alprazolam) 1 mg tablets 4 tablets
Xanax (alprazolam) 2 mg tablets 3 tablets
Niravam (alprazolam) 0.25 mg orally
disintegrating tablets4 tablets
Niravam (alprazolam) 0.5 mg orally
disintegrating tablets4 tablets
Niravam (alprazolam) 1 mg orally disintegrating
tablets4 tablets
Niravam (alprazolam) 2 mg orally disintegrating
tablets3 tablets
Xanax XR (alprazolam SR) 0.5 mg extended-release
tablets1 tablet
Xanax XR (alprazolam SR) 1 mg extended-release
tablets1 tablet
Xanax XR (alprazolam SR) 2 mg extended-release
tablets2 tablets
Quantity limits apply to Medicaid only.
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 23
Minnesota Medicaid Quantity Limit Program Criteria
Xanax XR (alprazolam SR) 3 mg extended-release
tablets2 tablets
Alprazolam Intensol (alprazolam) 1 mg/1mL concentrate 6 mLs
Librium (chlordiazepoxide) 5 mg capsules 4 capsules
Librium (chlordiazepoxide) 10 mg capsules 4 capsules
Librium (chlordiazepoxide) 25 mg capsules 4 capsules
Limbitrol (chlordiazepoxide/amitriptyline) 5mg/12.5mg tablets 4 tablets
Limbitrol (chlordiazepoxide/amitriptyline) 10mg/25mg tablets 6 tablets
Onfi (clobazam) 10 mg tablets 2 tablets
Onfi (clobazam) 20 mg tablets 2 tablets
Onfi (clobazam) 2.5 mg/mL suspension 16 mLs
Sympazan (clobazam) 5 mg oral film 8 films
Sympazan (clobazam) 10 mg oral film 2 films
Sympazan (clobazam) 20 mg oral film 2 films
Klonopin (clonazepam) 0.5 mg tablets 3 tablets
Klonopin (clonazepam) 1 mg tablets 3 tablets
Klonopin (clonazepam) 2 mg tablets 2 tablets
Klonopin (clonazepam) 0.125 mg orally
disintegrating tablets3 tablets
Klonopin (clonazepam) 0.25 mg orally
disintegrating tablets3 tablets
Klonopin (clonazepam) 0.5 mg orally
disintegrating tablets3 tablets
Klonopin (clonazepam) 1 mg orally disintegrating
tablets3 tablets
Klonopin (clonazepam) 2 mg orally disintegrating
tablets2 tablets
Tranxene (clorazepate) 3.75 mg tablets 3 tablets
Tranxene (clorazepate) 7.5 mg tablets 3 tablets
Tranxene (clorazepate) 15 mg tablets 4 tablets
Valium (diazepam) 2 mg tablets 4 tablets
Valium (diazepam) 5 mg tablets 4 tablets
Valium (diazepam) 10 mg tablets 4 tablets
Diazepam (diazepam) 1 mg/1mL solution 40 mLs
Diazepam Intensol (diazepam) 5 mg/1mL concentrate 8 mLs
Diastat (diazepam) 2.5 mg rectal solution 2 twin packs per 30 days
Diastat (diazepam) 10 mg rectal solution 2 twin packs per 30 days
Diastat (diazepam) 20 mg rectal solution 2 twin packs per 30 days
Valtoco (diazepam) 5 mg/ 0.1 mL nasal
inhaler10 blister packs (5 boxes) per 30 days
Valtoco (diazepam) 10 mg/ 0.1 mL nasal
inhaler10 blister packs (5 boxes) per 30 days
Valtoco (diazepam) 15 mg (2 x 7.5 mg/ 0.1
mL) nasal inhaler10 blister packs (5 boxes) per 30 days
Valtoco (diazepam) 20 mg (2 x 10 mg/ 0.1
mL) nasal inhaler10 blister packs (5 boxes) per 30 days
Prosom (estazolam) 1 mg tablets 1 tablet
Prosom (estazolam) 2 mg tablets 1 tablet
Dalmane (flurazepam) 15 mg capsules 1 capsule
Dalmane (flurazepam) 30 mg capsules 1 capsule
Ativan (lorazepam) 0.5 mg tablets 3 tablets
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 24
Minnesota Medicaid Quantity Limit Program Criteria
Ativan (lorazepam) 1 mg tablets 3 tablets
Ativan (lorazepam) 2 mg tablets 5 tablets
Ativan (lorazepam) 2 mg/1mL concentrate 5 mLs
Nayzilam (midazolam) 5mg/0.1mL nasal spray10 sprays per 30 days
Serax (oxazepam) 10 mg capsules 4 capsules
Serax (oxazepam) 15 mg capsules 4 capsules
Serax (oxazepam) 30 mg capsules 2 capsules
Doral (quazepam) 15 mg tablets 1 tablet
Restoril (temazepam) 7.5 mg capsules 1 capsule
Restoril (temazepam) 15 mg capsules 1 capsule
Restoril (temazepam) 22.5 mg capsules 1 capsule
Restoril (temazepam) 30 mg capsules 1 capsule
Halcion (triazolam) 0.125 mg tablets 1 tablet
Halcion (triazolam) 0.25 mg tablets 2 tablets
Biologic Immunomodulators
PAQL
Bisphosphonates PS
AR1119_r0320
Actonel (risedronate) 5 mg tablets 1 tablet
Actonel (risedronate)a 30 mg tablets 1 tablet
Actonel (risedronate)a 35 mg tablets 4 tablets (1 dose pack)/28 days
Actonel (risedronate)a 150 mg tablets 1 tablet/month
Atelvia (risedronate delayed-release)a 35 mg delayed-release
tablets
4 tablets (1 dose pack)/28 days
Binosto (alendronate) 70 mg effervescent
tablets
4 tablets /28 days
Boniva (ibandronate)a 150 mg tablets 1 tablet (blister pack)/month
Boniva (ibandronate)a 3 mg/3 mL injection 3 mL (1 kit)/90 days
Fosamax/alendronate (alendronate)a 5 mg tablets 1 tablet
Fosamax/alendronate (alendronate)a 10 mg tablets 1 tablet
Fosamax/alendronate (alendronate)a 35 mg tablets 4 tablets (1 blister pack)/28 days
Fosamax/alendronate (alendronate) 40 mg tablets 1 tablet
Fosamax/alendronate (alendronate)a 70 mg tablets 4 tablets (1 blister pack)/28 days
Fosamax/alendronate (alendronate) 70 mg/75 mLs oral
solution
75 mLs (70 mg)/week
Fosamax Plus D 70 mg/2800 IU 4 tablets (1 blister pack)/28 daysFosamax Plus D
(alendroante/cholecalciferol)
70 mg/5600 IU
(alendronate/cholecalc
iferol)
4 tablets (1 blister pack)/28 days
c -IU=International Units a - product has been discontinued by the manufacturer but may still be available
Quantity limits apply to Medicaid.
**Biologic Immunomodulators QL information is included in the individual program document
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 25
Minnesota Medicaid Quantity Limit Program Criteria
Buprenorphine, Quantity limits apply to Medicaid.
buprenorphine-naloxone PS
AR0220_r0320
buprenorphinea 2 mg sublingual tablet 15 tablets/90 days
buprenorphinea 8 mg sublingual tablet 15 tablets/90 days
Bunavail (buprenorphine/naloxone) 2.1 mg / 0.3 mg
buccal film
3 films
Bunavail (buprenorphine/naloxone) 4.2 mg / 0.7 mg
buccal film
2 films
Bunavail (buprenorphine/naloxone) 6.3 mg / 1 mg buccal
film
2 films
Suboxone (buprenorphine/naloxone)a 2 mg/0.5 mg
sublingual tablet
4 tablets
Suboxone (buprenorphine/naloxone)a 8 mg/2 mg sublingual
tablet
3 tablets
Suboxone (buprenorphine/naloxone)a 2 mg/0.5 mg
sublingual film
4 films
Suboxone (buprenorphine/naloxone)a 4 mg/1 mg sublingual
film
1 film
Suboxone (buprenorphine/naloxone)a 8 mg/2 mg sublingual
film
2 films
Suboxone (buprenorphine/naloxone)a 12 mg/3 mg
sublingual film
2 films
Zubsolv (buprenorphine/naloxone) 0.7 mg/0.18 mg
sublingual tablet
1 tablet
Zubsolv (buprenorphine/naloxone) 1.4 mg/0.36 mg
sublingual tablet
3 tablets
Zubsolv (buprenorphine/naloxone) 2.9 g/0.71 mg
sublingual tablet
1 tablet
Zubsolv (buprenorphine/naloxone) 5.7mg/1.4 mg
sublingual tablet
1 tablet
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 26
Minnesota Medicaid Quantity Limit Program Criteria
Zubsolv (buprenorphine/naloxone) 8.6 mg/2.1 mg
sublingual tablet
2 tablets
Zubsolv (buprenorphine/naloxone) 11.4 mg/2.9 mg
sublingual tablet
1 tablet
Cablivi QL ** Cablivi QL information is included in the individual program document
CGM QL ** CGM QL information is included in the individual program document
CGRP PAQL ** CGRP QL information is included in the individual program document
Ciclopirox_Efinaconazole_It
raconazole_Tavaborole_Ter
binafine_PAQL ** Ciclopirox_Efinaconazole_Itraconazole_Tavaborole_Terbinafine QL information is included in the individual program document
Circadian Rhythm Disorder
PAQL ** Circadian Rhythm Disorder QL information is included in the individual program document
Combination NSAID PAQL ** Combination NSAID QL information is included in the individual program document
Contraceptives PS
AR0220_r0320 Quantity limits apply to Medicaid only.
Estrogen/Progestin combinations, oral 28 tablets/21 days
Progestin combinations, oral 28 tablets/21 days
Xulane (norelgestromin /ethinyl estradiol
transdermal system)
6 mg norelgestromin,
0.75 mg ethinyl
estradiol.
3 patches/21 days
NuvaRing, Eluryng (etonogestrel/ethinyl
estradiol vaginal ring)
11.7 mg etonogestrel,
2.7 mg ethinyl
estradiol
1 vaginal ring/21 days
Annovera (segesterone acetate/ethinyl
estradiol vaginal system)
103 mg segesterone
acetate, 17.4 mg ethinyl
estradiol
1 vaginal system/365 days
DPP-4 Inhibitors PS AR0220_r0320 Glyxambi (empagliflozin/linagliptin) 10 mg / 5 mg 1 tablet
Glyxambi (empagliflozin/linagliptin) 25 mg / 5 mg 1 tablet
Januvia (sitagliptin) 25 mg tablet 1 tabletJanuvia (sitagliptin) 50 mg tablet 1 tabletJanuvia (sitagliptin) 100 mg tablet 1 tablet
Nesina (alogliptin) 6.25mg 1 tabletNesina (alogliptin) 12.5mg 1 tabletNesina (alogliptin) 25mg 1 tablet
Onglyza (saxagliptin) 2.5 mg tablet 1 tablet
Quantity limits apply to Medicaid.
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 27
Minnesota Medicaid Quantity Limit Program Criteria
Onglyza (saxagliptin) 5 mg tablet 1 tablet
Tradjenta (linagliptin) 5 mg tablet 1 tablet
Janumet (sitagliptin/metformin) 50 mg/500 mg tablet 2 tabletsJanumet (sitagliptin/metformin) 50 mg/1000 mg tablet 2 tablets
Janumet XR (sitagliptin/metformin extended- 50 mg/500 mg tablet 1 tabletJanumet XR (sitagliptin/metformin extended- 50 mg/1000 mg tablet 2 tabletsJanumet XR (sitagliptin/metformin extended- 100 mg/1000 mg tablet 1 tablet
Jentadueto (linagliptin/metformin) 2.5 mg/500 mg tablet 2 tabletsJentadueto (linagliptin/metformin) 2.5 mg/850 mg tablet 2 tabletsJentadueto (linagliptin/metformin) 2.5 mg/1000 mg tablet 2 tablets
Jentadueto XR (linagliptin/metformin ER) 2.5 mg/1000 mg 2 tablets
Jentadueto XR (linagliptin/metformin ER) 5 mg/1000 mg tablet 1 tablet
DPP-4 Inhibitors PSAR0220_r0320 Kazano (alogliptin/metformin) 12.5mg/500mg 2 tablets
Kazano (alogliptin/metformin) 12.5mg/100mg 2 tablets
Kombiglyze XR (saxagliptin/metformin) 2.5 mg/1000 mg tablet 2 tabletsKombiglyze XR (saxagliptin/metformin) 5 mg/500 mg tablet 1 tabletKombiglyze XR (saxagliptin/metformin) 5 mg/1000 mg tablet 1 tablet
Oseni (alogliptin/pioglitazone) 12.5mg/15mg 1 tabletOseni (alogliptin/pioglitazone) 12.5mg/30mg 1 tabletOseni (alogliptin/pioglitazone) 12.5mg/45mg 1 tabletOseni (alogliptin/pioglitazone) 25mg/15mg 1 tabletOseni (alogliptin/pioglitazone) 25mg/30mg 1 tabletOseni (alogliptin/pioglitazone) 25mg/45mg 1 tablet
Qtern (dapagliflozin/saxagliptin) 5 mg/5 mg tablet 1 tabletQtern (dapagliflozin/saxagliptin) 10 mg/5 mg tablet 1 tablet
Steglujan (ertugliflozin/sitagliptin) 5 mg/100 mg tablet 1 tabletSteglujan (ertugliflozin/sitagliptin) 15 mg/100 mg tablet 1 tablet
Trijardy XR
(empagliflozin/linagliptin/metformin ER)
5 mg/2.5 mg/1000 mg tablet 2 tablets
Trijardy XR
(empagliflozin/linagliptin/metformin ER)
10 mg/5 mg/1000 mg tablet 1 tablet
Trijardy XR
(empagliflozin/linagliptin/metformin ER)
12.5 mg/2.5 mg/1000 mg tablet 2 tablets
Trijardy XR
(empagliflozin/linagliptin/metformin ER)
25 mg/5 mg/1000 mg tablet 1 tablet
Egrifta PAQL ** Egrifta QL information is included in the individual program document
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 28
Minnesota Medicaid Quantity Limit Program Criteria
Fibrates PS AR0819_r0320
Antara (fenofibrate) 30 mg micronized capsules 2 capsules
Antara (fenofibrate)a 43 mg micronized
capsules
2 capsules
Antara (fenofibrate) 90 mg micronized capsules 1 capsule
Antara (fenofibrate)a 130 mg micronized
capsules
1 capsule
Fenoglide (fenofibrate)a 40 mg tablets 2 tablets
Fenoglide (fenofibrate)a 120 mg tablets 1 tablet
Fibricor (fenofibric acid) 35 mg tablets 2 tabletsFibricor (fenofibric acid) 105 mg tablets 1 tablet
Lipofen (fenofibrate) 50 mg capsules 2 capsulesLipofen (fenofibrate) 150 mg capsules 1 capsule
Lofibra (fenofibrate)a 54 mg tablets 2 tablets
Lofibra (fenofibrate)a 160 mg tablets 1 tablet
Lofibra (fenofibrate)a 67 mg micronized
capsules
1 capsule
Lofibra (fenofibrate)a 134 mg micronized
capsules
1 capsule
Lofibra (fenofibrate)a 200 mg micronized
capsules
1 capsule
Tricor (fenofibrate)a 48 mg tablets 2 tablets
Tricor (fenofibrate)a 145 mg tablets 1 tablet
Triglide (fenofibrate) 50 mg tablets 2 tabletsTriglide, Fenofibrate 160 mg tablets 1 tablet
Trilipix (fenofibric acid)a 45 mg delayed-release
tablets
2 tablets
Trilipix (fenofibric acid)a 135 mg delayed-release
tablets
1 tablet
Fibrates PS AR0819_r0320 Lopid (gemfibrozil)a 600 mg tablets 2 tablets
Fibromyalgia (Lyrica,
Savella) PS AR0320 Quantity limits apply to Medicaid.
Lyrica (pregabalin)a 25 mg capsule 3 capsules
Lyrica (pregabalin)a 50 mg capsule 3 capsules
Lyrica (pregabalin)a 75 mg capsule 3 capsules
Lyrica (pregabalin)a 100 mg capsule 3 capsules
Quantity limits apply to Medicaid.
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 29
Minnesota Medicaid Quantity Limit Program Criteria
Lyrica (pregabalin)a 150 mg capsule 3 capsules
Lyrica (pregabalin)a 200 mg capsule 3 capsules
Lyrica (pregabalin)a 225 mg capsule 2 capsules
Lyrica (pregabalin)a 300 mg capsule 2 capsules
Lyrica (pregabalin)a 20 mg/mL oral
solution
30 mLs
Savella (milnacipran) 12.5 mg tablet 2 tablets
Savella (milnacipran) 25 mg tablet 2 tablets
Savella (milnacipran) 50 mg tablet 2 tablets
Savella (milnacipran) 100 mg tablet 2 tablets
Savella (milnacipran) Titration pack: 5 x
12.5 mg, 8 x 25 mg,
42 x 50 mg tablets
1 pack/180 days
Gabapentin ER PS AR0320Quantity limits apply to Medicaid only.
Gralise (gabapentin) 300 mg extended-release
tablets1 tablet
Gralise (gabapentin) 600 mg extended-release
tablets3 tablets
Gralise (gabapentin) Starter Pack: 300 mg (9)
& 600 mg (69)1 pack/180 days
Horizant (gabapentin enacarbil) 300 mg extended-release
tablets2 tablets
Horizant (gabapentin enacarbil) 600 mg extended-release
tablets2 tablets
Galafold PAQL
GLP-1 PS AR0220_r0320
Adlyxin (lixisenatide) 20 mcg/injection 3 mL
pens
2 pens / 28 days
Adlyxin (lixisenatide) Starter Pack (2 pens) 2 pens / 180 days
Byetta (exenatide) 5 mcg/dose prefilled
pen
1 prefilled pen (60 doses)/30 days
Byetta (exenatide) 10 mcg/dose prefilled
pen
1 prefilled pen (60 doses)/30 days
Bydureon (exenatide ER) 2 mg/vial in single
dose tray; 4
trays/carton
1 carton (4 trays/4 doses)/28 days
Bydureon (exenatide ER) 2 mg/pen; 4
trays/carton
1 carton (4 doses)/28 days
** Galafold QL information is included in the individual program
Quantity limits apply to Medicaid only.
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 30
Minnesota Medicaid Quantity Limit Program Criteria
Bydureon BCise (exenatide ER) 2 mg/autoinjector; 4
autoinjector/carton
1 carton (4 doses)/28 days
Ozempic (semaglutide) 2 mg single-patient
pen (0.25-0.5 mg per
injection)
1 pen / 28 days
Ozempic (semaglutide) 2 mg single-patient
pen (1 mg per
injection)
2 pens / 28 days
Rybelsus (semaglutide) 3 mg tablet 30 tablets / 180 days
Rybelsus (semaglutide) 7 mg tablet 1 tablet
Rybelsus (semaglutide) 14 mg tablet 1 tablet
Tanzeum (albiglutide) 30 mg single-dose pen 4 pens/28 days
Tanzeum (albiglutide) 50 mg single-dose pen 4 pens/28 days
Trulicity (dulaglutide) 0.75 mg/0.5 mL
syringe and pens
4 pens or syringes/28days
Trulicity (dulaglutide) 1.5 mg/0.5 mL syringe
and pens
4 pens or syringes/28days
Victoza (liraglutide) 18 mg/3 mL pen 3 pens/30 days
Glucose Test
Strips/Disks/Meters QL
HAE PAQL
hATTR Amyloidosis
Neuropathy PAQL
HoFH PAQL
Ingrezza PAQL
Insomnia PS AR0320_r0520
Ambien (zolpidem)a 5 mg tablet 1 tablet
Ambien (zolpidem)a 10 mg tablet 1 tablet
Ambien CR (zolpidem)a 6.25 mg extended-
release tablet
1 tablet
Ambien CR (zolpidem)a 12.5 mg extended-
release tablet
1 tablet
Belsomra (suvorexant) 5 mg tablet 1 tablet
** Glucose Test Strips/Disks/Meters QL information is included in the individual program document
** hATTR Amyloidosis Neuropathy QL information is included in the individual program document
** HAE QL information is included in the individual program document
Quantity limits apply to Medicaid.
** Ingrezza QL information is included in the individual program document
** HoFH QL information is included in the individual program document
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 31
Minnesota Medicaid Quantity Limit Program Criteria
Belsomra (suvorexant) 10 mg tablet 1 tabletBelsomra (suvorexant) 15 mg tablet 1 tabletBelsomra (suvorexant) 20 mg tablet 1 tablet
Dayvigo (lemborexant) 5 mg tablet 1 tabletDayvigo (lemborexant) 10 mg tablet 1 tablet
Edluar (zolpidem) 5 mg sublingual tablet 1 tabletEdluar (zolpidem) 10 mg sublingual tablet 1 tablet
Intermezzo (zolpidem)a 1.75 mg sublingual tablet 1 tablet
Intermezzo (zolpidem)a 3.5 mg sublingual tablet 1 tablet
Lunesta (eszopiclone)a 1 mg tablet 1 tablet
Lunesta (eszopiclone)a 2 mg tablet 1 tablet
Lunesta (eszopiclone)a 3 mg tablet 1 tablet
Rozerem (ramelteon)a 8 mg tablet 1 tablet
Silenor, Doxepina 3 mg tablet 1 tablet
Silenor, Doxepina 6 mg tablet 1 tablet
Sonata (zaleplon)a 5 mg capsule 1 capsule
Sonata (zaleplon)a 10 mg capsule 1 capsule
ZolpiMist (zolpidem) Oral Spray 5
mg/actuation
1 canister (60 actuations)/ 30 days
Insulins CS AR0220_r0420
NovoLog, Insulin Aspart 100 U/mL: 10 mL vial 45 mL/30 days100 U/mL: 3 mL
pen/cartridge (Penfill)
45 mL/30 days
100 U/mL: 3 mL
pen/cartridge (Flexpen)
45 mL/30 days
Fiasp (insulin aspart) 100 U/mL: 10 mL vial 45 mL/30 days
100 U/mL: 3 mL
pen/cartridge (Penfill)
45 mL/30 days
100 U/mL: 3 mL
pen/cartridge
(Flextouch)
45 mL/30 days
Lantus (insulin glargine) 100 U/mL: 10 mL vial 45 mL/30 days
Quantity limits apply to Medicaid only.
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 32
Minnesota Medicaid Quantity Limit Program Criteria
100 U/mL: 3 mL
device/cartridge
(Solostar)
45 mL/30 days
Toujeo (insulin glargine) 300 U/mL: 1.5 mL pen 45 mL/30 daysToujeo Max (insulin glargine) 300 U/mL: 3 mL pen 45 mL/30 daysBasaglar Kwikpen (insulin glargine) 100 U/mL: 3 mL
pen/cartridge
45 mL/30 days
Apidra (insulin glulisine) 100 U/mL: 10 mL vial 45 mL/30 days100 U/mL: 3 mL
pen/cartridge (Solostar)
45 mL/30 days
Admelog (insulin lispro) 100 U/mL: 10 mL vial 45 mL/30 daysAdmelog (insulin lispro) 100 U/mL: 3 mL pen 45 mL/30 daysHumalog, Insulin Lispro 100 U/mL: 10 mL vial 45 mL/30 days
100 U/mL: 3 mL
pen/cartridge
45 mL/30 days
Humalog Junior Kwikpen U100, Insulin Lispro
Junior Kwikpen
100 U/mL: 3 mL pen 45 mL/30 days
Humalog Kwikpen U200 (insulin lispro) 200 U/mL: 3 mL pen 45 mL/30 daysLevemir (insulin detemir) 100 U/mL: 10 mL vial 45 mL/30 days
100 U/mL: 3 mL pen
(Flexpen, Flextouch)
45 mL/30 days
Tresiba (insulin degludec) 100 U/mL: 3 mL pen 45 mL/30 daysTresiba (insulin degludec) 200 U/mL: 3 mL pen 45 mL/30 daysTresiba (insulin degludec) 100 U/mL: 10 mL vial 45 mL/30 daysHumulin R, Novolin R, Relion R (insulin
regular)
100 U/mL: 10 mL vial 45 mL/30 days
Humulin R (insulin regular) 500 U/mL: 20 mL vial 45 mL/30 daysNovolin R 100 U/mL: 3 mL pen 45 mL/30 daysHumulin R Kwikpen U500 (insulin regular) 500 U/mL: 3 mL pen 45 mL/30 days
Humulin N, Novolin N, (insulin isophane) 100 U/mL: 10 mL vial 45 mL/30 daysHumulin N, Novolin N, (insulin isophane) 100 U/mL: 3 mL pen 45 mL/30 daysNovoLog 70/30 (insulin mixed) 100 U/mL: 10 mL vial 45 mL/30 days
100 U/mL: 3 mL pen
(Flexpen)
45 mL/30 days
Humulin 70/30, Novolin 70/30, Relion 70/30 100 U/mL: 10 mL vial 45 mL/30 days
Humulin 70/30, Novolin 70/30 100 U/mL: 3 mL pen
(Kwikpen, Flexpen)
45 mL/30 days
Humalog 75/25 (insulin mixed) 100 U/mL: 10 mL vial 45 mL/30 daysHumalog Kwikpen 75/25 (insulin mixed);
Insulin Lispro Protamine/Insulin Lispro
100 U/mL: 3 mL pen 45 mL/30 days
Humalog 50/50 (insulin mixed) 100 U/mL: 10 mL vial 45 mL/30 daysHumalog Kwikpen 50/50 (insulin mixed) 100 U/mL: 3 mL pen 45 mL/30 daysAfrezza 4 unit cartridge packs 2,520 cartridges / 30 days
Afrezza 8 unit cartridge packs 1,260 cartridges / 30 days
Afrezza 12 unit cartridge
packs
900 cartridges / 30 days
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 33
Minnesota Medicaid Quantity Limit Program Criteria
Afrezza 30 X 4 unit cartridge +
60 X 8 unit cartridge mix
packs
1,530 cartridges / 30 days
Afrezza 60 X 4 unit cartridge +
30 X 8 unit cartridge mix
packs
1,890 cartridges / 30 days
Afrezza 60 x 8 unit cartridge +
30 x 12 unit cartridge
mix packs
1,080 cartridges / 30 days
Afrezza 90 x 4 unit cartridge +
90 x 8 unit cartridge
mix packs
1,800 cartridges / 30 days
Afrezza 90 x 8 unit cartridge +
90 x 12 unit cartridge
mix packs
1,080 cartridges / 30 days
Afrezza 60 x 4 unit cartridge +
60 x 8 unit cartridge +
60 x 12 unit cartridge
mix packs
1,260 cartridges / 30 days
Insulin Combination PS
AR0220_r0320
Quantity limits apply to Medicaid.
Soliqua (insulin glargine/lixisenatide) 100 units/mL insulin
glargine / 33 mcg/mL
lixisenatide
15 mL (5 pens) / 30 days
Xultophy (insulin degludec/liraglutide) 100 units/mL insulin
degludec / 3.6 mg
liraglutide
15 mL (5 pens) / 30 days
Jynarque PAQL ** Jynarque QL information is included in the individual program document
Kalydeco Orkambi PAQL ** Kalydeco Orkambi QL information is included in the individual program document
Ketorolac PS AR0220_r0320 Quantity limits apply to Medicaid.
Ketorolaca
10 mg tablet 20 tablets/prescription
Sprix (ketorolac nasal spray) 1.7 g bottle 5 bottles/prescriptionSprix (ketorolac nasal spray) 1.7 g bottle (5 pack) 1 pack/prescription
Keveyis PS AR0320 Quantity limits apply to Medicaid. Keveyis 50 mg tablet 4 tablets
Low Molecular Weight Quantity limits apply to Medicaid.
a - available as a generic, included in quantity limit program
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 34
Minnesota Medicaid Quantity Limit Program Criteria
Heparins (LMWH) and Arixtra (fondaparinux)
Arixtra PS AR0320 Single-dose syringea 2.5 mg/ 0.5 ml 30 syringes/90 days
Single-dose syringea 5 mg/ 0.4 ml 30 syringes/90 days
Single-dose syringea 7.5 mg/0.6 ml 30 syringes/90 days
Single-dose syringea 10 mg/ 0.8 ml 30 syringes/90 days
Fragmin (dalteparin) Single-dose syringe 2,500 IU/ 0.2 ml 30 syringes/90 days Single-dose syringe 5,000 IU/ 0.2 ml 30 syringes/90 days Single-dose syringe 7,500 IU /0.3 ml 30 syringes/90 days
Low Molecular Weight Single-dose graduated syringe 10,000 IU/ 1 ml 30 syringes/90 days
Heparins (LMWH) and Single-dose syringe 12,500 IU/0.5 ml 30 syringes/90 days
Arixtra PS AR0320 Single-dose syringe 15,000 IU/ 0.6 ml 30 syringes/90 days Single-dose syringe 18,000 IU/ 0.72 ml 30 syringes/90 days
Multi-dose vial95,000 IU/3.8 mL
(25,000 IU/ 1 mL)10 vials/90 days
Lovenox (enoxaparin)
Single-dose syringe 30 mg/ 0.3 mla 30 syringes/90 days
Single-dose syringe 40 mg/ 0.4 mla 30 syringes/90 days
Single-dose graduated syringe 60 mg/ 0.6 mla 30 syringes/90 days
Single-dose graduated syringe 80 mg/ 0.8 mla 30 syringes/90 days
Single-dose graduated syringe 100 mg/ 1 mla 30 syringes/90 days
Single-dose graduated syringe 120 mg/ 0.8 mla 30 syringes/90 days
Single-dose graduated syringe 150 mg/ 1 mla 30 syringes/90 days
Multiple dose vial 300 mg/ 3 mla 10 vials/90 days
Lucemyra PAQL
Lyrica CR PS AR0520Lyrica CR (pregabalin ER) 82.5 mg tablet 1 tabletLyrica CR (pregabalin ER) 165 mg tablet 1 tabletLyrica CR (pregabalin ER) 330 mg tablet 2 tablets
Metformin ER PS
AR0220_r0320
Fortamet (metformin osmotic ER) 500 mg 3 tablets
Fortamet (metformin osmotic ER) 1000 mg 2 tablets
Glucophage XR (metformin ER) 500 mg 4 tablets
Glucophage XR (metformin ER) 750 mg 2 tablets
Glumetza (metformin modified release
ER)
500 mg 3 tablets
Glumetza (metformin modified release
ER)
1000 mg 2 tablets
Riomet ER supsension (metformin ER) 500 mg/5 mL 960 mL/30 days
Multiple Sclerosis PAQL
Quantity limits apply to Medicaid only.
**Multiple Sclerosis QL information is included in the individual program document
**Lucemyra QL information is included in the individual program document
Quantity limits apply to Medicaid.
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 35
Minnesota Medicaid Quantity Limit Program Criteria
Nasal Inhalers PS
AR0220_r0320Antihistamines
azelastine 0.1%a 137 mcg/spray (30 mL,
200 sprays) 2 bottles/30 days
Astepro (azelastine 0.15%) 205.5 mcg/spray (30
mL, 200 sprays) 2 bottles/30 days
Patanase (olopatadine)a 665 mcg/spray (30.5
gm, 240 sprays) 1 bottle/30 days
Anticholinergics
Atrovent (ipratropium 0.03%)a 21 mcg/spray (30 mL,
345 sprays) 2 bottles/30 days
Atrovent (ipratropium 0.06%)a 42 mcg/spray (15 mL,
165 sprays) 3 bottles/30 days
CorticosteroidsBeconase AQ (beclomethasone) 42 mcg/spray (25 gm,
180 sprays) 2 bottles/30 days
Flonase (fluticasone propionate)a 50 mcg/spray (16 gm,
120 sprays) 1 bottle/30 days
Flunisolidea 25 mcg/spray (25 mL,
200 sprays) 3 bottles/30 days
Nasacort AQ (triamcinolone)b 55 mcg/spray (16.5 gm,
120 sprays) 1 bottle/30 days
Nasonex (mometasone)a 50 mcg/spray (17 gm,
120 sprays) 2 bottles/30 days
Omnaris (ciclesonide) 50 mcg/spray (12.5 gm,
120 sprays) 1 bottle/30 days
Qnasl (beclomethasone diproprionate) 80 mcg/spray (10.6 gm,
120 sprays) 1 canister/30 days
Qnasl Children (beclomethasone
diproprionate)
40 mcg/spray (6.8 gm,
60 sprays) 1 canister/30days
Rhinocort Aqua (budesonide)b 32 mcg/spray (8.6 gm,
120 sprays) 2 bottles/30 days
Xhance (fluticasone) 93 mcg/actuation (16
mLs, 120 sprays) 2 bottles/30 days
Quantity limits apply to Medicaid.
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 36
Minnesota Medicaid Quantity Limit Program Criteria
Zetonna (ciclesonide) 37 mcg/actuation (6.1
gm, 60 actuations) 1 canister/30 days
Nasal Inhalers PS
AR0220_r0320
Combinations
Dymista (azelastine/fluticasone)a
137 mcg/50 mcg/spray
(23 gm, 120 sprays) 1 bottle/30 days
Neprilysin Inhibitor PAQL ** Neprilysin Inhibitor QL information is included in the individual program document
Niaspan PS AR0819_r0320Niaspan (niacin extended-release) 500 mg extended-release
tablets
1 tablet
Niaspan (niacin extended-release) 750 mg extended-release
tablets
2 tablets
Niaspan (niacin extended-release) 1000 mg extended-
release tablets
2 tablets
Noctiva PAQL ** Noctiva QL information is included in the individual program document
Northera PAQL ** Northera QL information is included in the individual program document
Ocaliva PAQL ** Ocaliva QL information is included in the individual program document
Opioids ER QL ** Opioids ER QL information is included in the individual program document
Opioids IR QL ** Opioids IR QL information is included in the individual program document
Oral Inhalers PS
AR0220_r0320Quantity limits apply to Medicaid.
Atrovent HFA (ipratropium)
17 mcg/actuation (12.9
gm, 200 actuations) 2 canisters/month
Combivent Respimat (ipratropium/albuterol)
18 mcg/90 mcg/actuation
(14.7gm, 200 actuations) 2 canisters/month
Incruse Ellipta (umeclidinium) 62.5 mcg/blister 30 blisters/month
Seebri Neohaler (glycopyrrolate) 15.6 mcg/ inhalation (box of 60 capsules)60 inhalation capsule/month
Quantity limits apply to Medicaid.
Anticholinergics
a–available as a generic and included in quantity limit program
b - product discontinued
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 37
Minnesota Medicaid Quantity Limit Program Criteria
Spiriva Handihaler (tiotropium) 18 mcg/inhalation
(carton of 5, 30, or 90
capsules) 30 capsules/month
Spiriva Respimat (tiotropium)
1.25 mcg/actuation (4 g
cartridge) 1 cartridge/month
Spiriva Respimat (tiotropium)
2.5 mcg/actuation (4 g
cartridge) 1 cartridge/month
Tudorza Pressair (aclidium bromide)
400 mcg/actuation (60
actuations) 1 canister/month
Short-Acting Beta AgonistsProAir HFA (albuterol sulfate HFA) 90 mcg/actuation (8.5
gm, 200 actuations) 2 canisters/month
Proventil HFA (albuterol sulfate) 90 mcg/actuation (6.7
gm, 200 actuations) 2 canisters/month
ProAir Respiclick (albuterol sulfate) 90 mcg/actuation (200
actuations) 2 inhalers/month
ProAir Digihaler (albuterol sulfate) 90 mcg/actuation (200
actuations) 2 inhalers/month
Ventolin HFA, Albuterol sulfate HFA
90 mcg/actuation (18
gm, 200 actuations) 2 canisters/month
Ventolin HFA (albuterol sulfate) 90 mcg/actuation (8 gm,
60 actuations) 2 canisters/month
Xopenex HFA, Levalbuterol HFA
45 mcg/actuation (15
gm, 200 actuations) 2 canisters/month
Long-Acting Beta AgonistsArcapta Neohaler (indacaterol)
75 mcg/inhalation
(Neohaler inhaler and
box of 5 blister cards of 6
capsules each, total 30) 1 box (30 capsules)/month
Foradil (formoterol)12 mcg/inhalation
(Aerolizer inhaler and
blister pack of 12 or 60) 1 blister pack of 12 or 1 blister pack of 60/month
Serevent (salmeterol)50 mcg/inhalation
(disposable inhalation
device and 60 blisters) 1 package (60 blisters)/month
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 38
Minnesota Medicaid Quantity Limit Program Criteria
Striverdi Respimat (olodaterol) 2.5 mcg/actuation (4 gm,
60 actuations) 1 canister/month
Corticosteroids and Corticosteroid
CombinationsAdvair Diskus (fluticasone/salmeterol) 100 mcg/50 mcg
(inhalation device, 60
blisters) 1 package (60 blisters)/month
Advair Diskus (fluticasone/salmeterol) 250 mcg/50 mcg per
inhalation (disposable
inhalation device and 60
blisters) 1 package (60 blisters)/month
Advair Diskus (fluticasone/salmeterol) 500 mcg/50 mcg per
inhalation (disposable
inhalation device and 60
blisters) 1 package (60 blisters)/month
Advair HFA (fluticasone/ salmeterol) 45 mcg/21 mcg (12 gm,
120 actuations) 1 canister/month
Advair HFA (fluticasone/ salmeterol) 115 mcg/21 mcg (12 gm,
120 actuations) 1 canister/month
Advair HFA (fluticasone/ salmeterol) 230 mcg/21 mcg (12 gm,
120 actuations) 1 canister/month
Aerospan (flunisolide)
80 mcg/actuation (8.9
gm, 120 actuations) 2 canisters/month
AirDuo Respiclick,
Fluticasone/Salmeterol
55 mcg/14 mcg (0.45
gm, 60 actuations)
1 inhaler/month
AirDuo Respiclick,
Fluticasone/Salmeterol
113 mcg/14 mcg
(0.45 gm, 60
actuations)
1 inhaler/month
AirDuo Respiclick,
Fluticasone/Salmeterol
232 mcg/14 mcg
(0.45 gm, 60
actuations)
1 inhaler/month
Alvesco (ciclesonide) 80 mcg/actuation (6.1
gm, 60 actuations) 1 canister/month
Oral Inhalers PS
AR0220_r0320
Alvesco (ciclesonide)160 mcg/actuation (6.1
gm, 60 actuations) 2 canisters/month
Armonair Respiclick (fluticasone) 55 mcg/actuation (0.9
g, 60 actuations)
1 inhaler/month
Armonair Respiclick (fluticasone) 113 mcg/actuation
(0.9 g, 60 actuations)
1 inhaler/month
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 39
Minnesota Medicaid Quantity Limit Program Criteria
Armonair Respiclick (fluticasone) 232 mcg/actuation
(0.9g, 60 actuations)
1 inhaler/month
Arnuity Ellipta (fluticasone) 50 mcg/blister 30 blisters/monthArnuity Ellipta (fluticasone) 100 mcg/blister 30 blisters/monthArnuity Ellipta (fluticasone) 200 mcg/blister 30 blisters/month
Asmanex (mometasone) 110 mcg/actuation (30
actuations) 1 canister/month
Asmanex (mometasone)220 mcg/actuation (30,
60, 120 actuations) 1 canister/month
Asmanex HFA (mometasone)
50 mcg/actuation (13
gm, 120 actuations) 1 canister/month
Asmanex HFA (mometasone)
100 mcg/actuation (13
gm, 120 actuations) 1 canister/month
Asmanex HFA (mometasone)
200 mcg/actuation (13
gm, 120 actuations) 1 canister/month
Breo Ellipta (fluticasone/valnterol)
100 mcg/25 mcg (60
blisters, 30 actuations) 1 package (60 blisters)/month
Breo Ellipta (fluticasone/valnterol)
200 mcg/25 mcg (60
blisters, 30 actuations) 1 package (60 blisters)/month
Dulera (mometasone/formoterol) 50 mcg/5 mcg (13 gm,
120 actuations) 1 canister/month
Dulera (mometasone/formoterol) 100 mcg/5 mcg (13 gm,
120 actuations) 1 canister/month
Dulera (mometasone/formoterol) 200 mcg/5 mcg (13 gm,
120 actuations) 1 canister/month
Flovent HFA (fluticasone)44 mcg/actuation (10.6
gm, 120 actuations) 1 canister/month
Flovent HFA (fluticasone) 110 mcg/actuation (12
gm, 120 actuations) 1 canister/month
Flovent HFA (fluticasone) 220 mcg/actuation (12
gm, 120 actuations) 2 canisters/month
Flovent Diskus (fluticasone) 50 mcg/inhalation (60
blisters/carton) 1 carton/month
Flovent Diskus (fluticasone) 100 mcg/inhalation (60
blisters/carton) 1 carton/month
Flovent Diskus (fluticasone) 250 mcg/inhalation (60
blisters/carton) 4 cartons/month
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 40
Minnesota Medicaid Quantity Limit Program Criteria
Pulmicort Flexhaler (budesonide) 90 mcg/actuation (60
actuations) 1 canister/month
Pulmicort Flexhaler (budesonide) 180 mcg/actuation (120
actuations) 2 canisters/month
Qvar (beclomethasone) 40 mcg/actuation (8.7
gm, 120 actuations) 1 canister/month
Qvar (beclomethasone) 80 mcg/actuation (8.7
gm, 120 actuations) 2 canisters/month
Qvar Redihaler 40 mcg/actuation
(10.6 gm, 120
actuations) 1 canister/month
Qvar Redihaler 80 mcg/actuation
(10.6 gm, 120
actuations) 2 canisters/month
Symbicort, Budesonide/formoterol 80 mcg/4.5 mcg (10.2
gm, 120 actuations) 1 canister/month
Symbicort, Budesonide/formoterol160 mcg/4.5 mcg (10.2
gm, 120 actuations) 1 canister/month
Trelegy Ellipta
(fluticasone/umeclidinium/vilanterol)
100 mcg/62.5 mcg/25
mcg (30 inhalations)1 inhaler/month
Anticholinergic/Long-Acting Beta Agonist Combination
Anoro Ellipta (umeclidinium/valnterol)
62.5 mcg/25 mcg (60
blisters, 30 actuations) 1 package (60 blisters)/month
Bevespi Aerosphere (glycopyrrolate and
formoterol)
9 mcg/4.8 mcg (120
inhalation canister) 1 canister/month
Duaklir Pressair (aclidinium
bromide/formoterol fumarate)
400 mcg/12 mcg (60
actuations) 1 inhaler/month
Stiolto Respimat (tiotropium/olodaterol) 2.5 mcg/2.5 mcg (4
grams, 60 actuations)
1 cartridge/month
Utibron Neohaler (indacaterol/glycopyrrolate)27.5 mcg/15.6
mg/inhalation (Box of
60 inhalation capsules/month
Ophthalmic
Immunomodulators PAQL ** Ophthalmic Immunomodulators QL information is included in the individual program document
Ophthalmic Prostaglandins
PS AR0819_r0320Lumigan (bimatoprost–0.01%) 2.5 mL bottle 2.5 mL/30 daysLumigan (bimatoprost–0.01%) 5 mL bottle 2.5 mL/30 daysLumigan (bimatoprost–0.01%) 7.5 mL bottle 2.5 mL/30 days
b – CFC-containing inhaler mandated by FDA to be phased out by December 31, 2013
Quantity limits apply to Medicaid.
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 41
Minnesota Medicaid Quantity Limit Program Criteria
Bimatoprost-0.03%a 2.5 mL bottle 2.5 mL/30 days
Bimatoprost-0.03%a 5 mL bottle 2.5 mL/30 days
Bimatoprost-0.03%a 7.5 mL bottle 2.5 mL/30 days
Rescula (unoprostone-0.15%) 5 mL bottle 5 mL/30 days
Travatan Z (travoprost)a 2.5 mL bottle 2.5 mL/30 days
Travatan Z (travoprost)a 5 mL bottle 2.5 mL/30 days
Travoprost 2.5 mL bottle 2.5 mL/30 daysTravoprost 5 mL bottle 2.5 mL/30 days
Vyzulta (latanoprostene bunod) 2.5 mL bottle 2.5 mL/30 daysVyzulta (latanoprostene bunod) 5 mL bottle 2.5 mL/30 days
Xalatan (latanoprost)a 2.5 mL bottle 2.5 mL/30 days
Xelpros (latanoprost emulsion) 2.5 mL bottle 2.5 mL/30 days
Zioptan (tafluprost)0.3 mL/single-use
container
30 single-use containers/30 days
Zioptan (tafluprost)0.3 mL/single-use
container
30 single-use containers/30 days
a–available as a generic and included in quantity limit program
Oral PAH PAQL ** Oral PAH QL information is included in the individual program document
Orilissa PAQL ** Orilissa QL information is included in the individual program document
Otezla PAQL
Oxbryta PAQL
Oxycodone ER PAQL ** Oxycodone ER QL information is included in the individual program document
Pain PS AR0220_r0320Butalbital Combinations
Allzital (butalbital/acetaminophen) 25 mg/325 mg tablet 12 tablets
Butalbital/Aspirin/Caffeine 50 mg/325 mg/40 mg
tablet
6 tablets
Tencon (butalbital/acetaminophen)a 50 mg/325 mg tablet 6 tablets
Vanatol LQ elixir, Vanatol S
(butalbital/acetaminophen/caffeine)a
50 mg/325 mg/40 mg/15
mL solution
90 mLs
Butalbital/Acetaminophen/Caffeinea 50 mg/325 mg/40 mg
capsule
6 capsules
Esgic (butalbital/acetaminophen/caffeine)a 50 mg/325 mg/40 mg
tablet
6 tablets
Fioricet (butalbital/acetaminophen/caffeine)a 50 mg/325 mg/40 mg
tablet
6 tablets
Quantity limits apply to Medicaid formularies.
** Otezla QL information is included in the individual program document
** Oxbryta QL information is included in the individual program document
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 42
Minnesota Medicaid Quantity Limit Program Criteria
Fioricet (butalbital/acetaminophen/caffeine)a 50 mg/300 mg/40 mg
tablet
6 tablets
Fiorinal (butalbital/aspirin/caffeine)a 50 mg/325 mg/40 mg
capsule
6 capsules
Fioricet (butalbital/acetaminophen/caffeine)a 50 mg/300 mg/40 mg
capsule
6 capsules
butalbital/acetaminophena 50 mg/300 mg tablets 6 tablets
Butal/APAP (bultalbital/acetaminophen)a 50 mg/300 mg capsule 6 capsules
a - available as a generic, included in quantity limit program
Parathyroid Hormone
Analogs for Osteoporosis
PAQL
PCSK9 PAQL ** PCSK9 QL information is included in the individual program document
Peanut Allergy PAQL **Peanut Allergy QL information is included in the individual program document
PPIs QL
Pseudobulbar Affect PAQL **Pseudobulbar Affect QL information is included in the individual program document
SA Oncology PAQL **SA Oncology QL information is included in the individual program document
Samsca PAQL **Samsca QL information is included in the individual program document
SGLT2 Inhibitors PS
AR0220_r0320Farxiga (dapagliflozin) 5 mg tablet 1 tabletFarxiga (dapagliflozin) 10 mg tablet 1 tablet
Invokana (canagliflozin) 100 mg tablet 1 tabletInvokana (canagliflozin) 300 mg tablet 1 tablet
Invokamet (canagliflozin/metformin) 50 mg / 500 mg 2 tabletsInvokamet (canagliflozin/metformin) 50 mg / 1000 mg 2 tabletsInvokamet (canagliflozin/metformin) 150 mg / 500 mg 2 tabletsInvokamet (canagliflozin/metformin) 150 mg / 1000 mg 2 tablets
Invokamet XR (canagliflozin/metformin ER) 50 mg/500 mg tablet 2 tablets
Invokamet XR (canagliflozin/metformin ER) 50 mg/1000 mg tablet 2 tablets
Invokamet XR (canagliflozin/metformin ER) 150 mg/500 mg tablet 2 tablets
Invokamet XR (canagliflozin/metformin ER) 150 mg/1000 mg tablet 2 tablets
** PPI QL information is included in the individual program document
Quantity limits apply to Medicaid.
** Parathyroid Hormone Analogs for Osteoporosis QL information is included in the individual program document
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 43
Minnesota Medicaid Quantity Limit Program Criteria
Jardiance (empagliflozin) 10 mg 1 tabletJardiance (empagliflozin) 25 mg 1 tablet
Segluromet (ertugliflozin/metformin) 2.5 mg/500 mg tablet 4 tabletsSegluromet (ertugliflozin/metformin) 2.5 mg/1000 mg tablet 2 tablets
Segluromet (ertugliflozin/metformin) 7.5 mg/500 mg tablet 2 tabletsSegluromet (ertugliflozin/metformin) 7.5 mg/1000 mg tablet 2 tablets
Steglatro (ertugliflozin) 5 mg tablet 2 tabletsSteglatro (ertugliflozin) 15 mg tablet 1 tablet
Synjardy (empagliflozin/metformin) 5 mg / 500 mg 2 tabletsSynjardy (empagliflozin/metformin) 5 mg / 1000 mg 2 tabletsSynjardy (empagliflozin/metformin) 12.5 mg / 500 mg 2 tabletsSynjardy (empagliflozin/metformin) 12.5 mg / 1000 mg 2 tablets
Synjardy XR (empagliflozin/metformin ER) 5 mg/1000 mg tablet 2 tablets
Synjardy XR (empagliflozin/metformin ER) 10 mg/1000 mg tablet 2 tablets
Synjardy XR (empagliflozin/metformin ER) 12.5 mg/1000 mg tablet 2 tablets
Synjardy XR (empagliflozin/metformin ER) 25 mg/1000 mg tablet 1 tablet
Xigduo XR (dapagliflozin/metformin ER) 2.5 mg/1000 mg tablet 2 tablets
Xigduo XR (dapagliflozin/metformin ER) 5 mg / 500 mg 1 tabletXigduo XR (dapagliflozin/metformin ER) 5 mg / 1000 mg 2 tabletsXigduo XR (dapagliflozin/metformin ER) 10 mg / 500 mg 1 tabletXigduo XR (dapagliflozin/metformin ER) 10 mg / 1000 mg 1 tablet
SSIA PS AR0520
Nuplazid (pimavanserin) 10 mg tablet 1 tabletNuplazid (pimavanserin) 17 mg tablet 2 tabletsNuplazid (pimavanserin) 34 mg capsule 1 capsule
Sunosi PAQL **Sunosi QL information is included in the individual program document
Symlin CS AR0220_r0320
Symlin (pramlintide) 60 pen-injector 4 pens (6 mL) / 30 days
Symlin (pramlintide) 120 pen-injector 4 pens (10.8 mL) / 30 days
TIRF PAQL **TIRF QL information is included in the individual program document
Topical Corticosteroids PS
AR1219_r0520
Quantity limits apply to Medicaid.
Quantity limits apply to Medicaid.
Quantity limits apply to Medicaid.
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 44
Minnesota Medicaid Quantity Limit Program Criteria
alclometasone dipropionate 0.05% cream (15 gm,
45 gm, 60 gm) 120 grams/30 days
alclometasone dipropionate 0.05% ointment (15
gm, 45 gm, 60 gm) 120 grams/30 days
Ala Scalp (hydrocortisone) 2% lotion (29.6 mL) 118.4 mLs/30 days
ApexiCon E (diflorasone diacetate) 0.05% emollient
cream (30 mg, 60 gm)120 grams/30 days
triamcinolone acetonide 0.5% ointment (15
gm) 120 grams/30 days
Bryhali (halobetasol propionate) 0.01% lotion (60 gm,
100 gm) 200 grams/28 days
Capex (fluocinolone acetonide) 0.01% shampoo (120
mL) 840 mLs/28 days
Clobex (clobetasol propionate) 0.05% spray (59 mL,
125 mL) 236 mLs/28 days
Clobex (clobetasol propionate) 0.05% lotion (59 mL,
118 mL) 177 mLs/28 days
Clobex (clobetasol propionate) 0.05% shampoo (118
mL) 236 mLs/30 days
Cloderm (clocortolone pivalate) 0.1% cream (30 gm,
45 gm, 75 gm, 90 gm)135 grams/30 days
Cordran (flurandrenolide) 4 mcg/cm2 (80 in x 3
in) 1 box/30 days
Cordran (flurandrenolide) 0.025% cream (120
gm) 120 grams/30 days
Cordran (flurandrenolide) 0.05% cream (60 gm,
120 gm) 120 grams/30 days
Cordran (flurandrenolide) 0.05% lotion (120 mL)120 mLs/30 days
Cordran (flurandrenolide) 0.05% ointment (60
gm) 120 grams/30 days
Cutivate (fluticasone propionate) 0.05% lotion (60 mL,
120 mL) 120 mLs/30 days
fluticasone propionate 0.05% cream (15 gm,
30 gm, 60 gm) 120 grams/30 days
fluticasone propionate 0.005% ointment (15
gm, 30 gm, 60 gm) 120 grams/30 days
Amcinonide 0.1% cream (15 gm,
30 gm, 60 gm) 120 grams/30 days
Amcinonide 0.1% lotion (60 mLs) 120 mLs/30 days
Amcinonide 0.1% ointment (60
gm) 120 grams/30 days
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 45
Minnesota Medicaid Quantity Limit Program Criteria
Derma-Smoothe (fluocinolone acetonide) 0.01% oil (body)
(118.28 mL) 118.28 mLs/30 days
Derma-Smoothe (fluocinolone acetonide) 0.01% oil (scalp)
(118.28 mL) 118.28 mLs/30 days
Prednicarbate 0.1% cream (60 gm) 120 grams/30 days
Prednicarbate 0.1% ointment (15
gm, 60 gm) 120 grams/30 days
Desonate (desonide) 0.05% gel (60 gm) 120 grams/30 days
desonide 0.05% lotion (59 mL,
118 mL) 118 mLs/30 days
DesOwen, Tridesilon (desonide) 0.05% cream (15 gm,
60 gm) 120 grams/30 days
desonide 0.05% ointment (15
gm, 60 gm) 120 grams/30 days
Diprolene, Bethamethasone dipropionate
augemented
0.05% gel (15 gm, 50
gm) 200 grams/28 days
bethamethasone dipropionate
augemented
0.05% lotion (30 mL,
60 mL) 210 mLs/30 days
Topical Corticosteroids PS
AR1219_r0520Diprolene (bethamethasone dipropionate
augemented)
0.05% ointment (15
gm, 45 gm, 50 gm) 200 grams/28 days
Diprolene AF (betamethasone
dipropionate)
0.05% cream (15 gm,
50 gm) 200 grams/28 days
betamethasone dipropionate 0.05% cream (15 gm,
45 gm) 135 grams/30 days
betamethasone dipropionate 0.05% lotion (60 mL) 120 mLs/30 days
betamethasone dipropionate 0.05% ointment (15
gm, 45 gm, 50 gm) 135 grams/30 days
Elocon (mometasone furoate) 0.1% cream (15 gm,
45 gm, 50 gm) 135 grams/30 days
mometasone furoate 0.1% ointment (15
gm, 45 gm) 135 grams/30 days
mometasone furoate 0.1% lotion/solution
(30 mL, 60 mL) 120 mLs/30 days
diflorasone diacetate 0.05% ointment (15
gm, 30 gm, 60 gm) 120 grams/30 days
Halog (halcinonide) 0.1% cream (30 gm,
60 gm, 216 gm) 240 grams/30 days
Halog (halcinonide) 0.1% ointment (30
gm, 60 gm) 240 grams/30 days
Halog (halcinonide) 0.1% solution (120
mL) 240 mLs/30 days
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 46
Minnesota Medicaid Quantity Limit Program Criteria
hydrocortisone 2.5% cream (3.5 gm,
20 gm, 28 gm, 28.35
gm, 30 gm, 453.6 gm,
454 gm) 454 grams/30 days
hydrocortisone 1% cream (28.35 gm,
28.4 gm, 30 gm,
453.6 gm, 454 gm) 454 grams/30 days
hydrocortisone 2.5% lotion (59 mL,
118 mL) 118 mLs/30 days
hydrocortisone 1% ointment (28.35
gm) 453.6 grams/30 days
hydrocortisone 2.5% ointment (20
gm, 28.35 gm, 30 gm,
453.6 gm, 454 gm)454 grams/30 days
Impoyz (clobetasol propionate) 0.025% cream (60
gm, 100 gm) 200 grams/28 days
Kenalog (triamcinolone acetonide) 0.147 mg/gm aerosol
spray (63 gm, 100
gm) 126 grams/30 days
triamcinolone acetonide 0.025% lotion (60 mL)120 mLs/30 days
triamcinolone acetonide 0.1% lotion (60 mL) 120 mLs/30 days
triamcinolone acetonide 0.025% ointment (15
gm, 80 gm, 454 gm) 454 grams/30 days
triamcinolone acetonide 0.025% cream (15
gm, 80 gm, 453.6 gm,
454 gm) 454 grams/30 days
triamcinolone acetonide 0.1% cream (15 gm,
28.4 gm, 30 gm, 45
gm, 80 gm, 453.6 gm,
454 gm) 454 grams/30 days
triamcinolone acetonide 0.5% cream (15 gm,
454 gm) 454 grams/30 days
triamcinolone acetonide 0.1% ointment (15
gm, 30 gm, 80 gm,
453.6 gm, 454 gm) 454 grams/30 days
Lexette, Halobetasol propionate 0.05% foam (50 gm) 200 grams/28 days
fluocinonide 0.05% solution (20
mL, 60 mL) 120 mLs/30 days
fluocinonide 0.05% cream (15 gm,
30 gm, 60 gm, 120
gm) 120 grams/30 days
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 47
Minnesota Medicaid Quantity Limit Program Criteria
fluocinonide 0.05% gel (15 gm, 30
gm, 60 gm) 120 grams/30 days
fluocinonide 0.05% ointment (15
gm, 30 gm, 60 gm) 120 grams/30 days
fluocinonide 0.05% emulsified
cream (15 gm, 30 gm,
60 gm) 120 grams/30 days
Topical Corticosteroids PS
AR1219_r0520Locoid (hydrocortisone butyrate) 0.1% solution (20 mL,
60 mL) 120 mLs/30 days
Locoid (hydrocortisone butyrate) 0.1% cream (15 gm,
45 gm) 135 grams/30 days
Locoid (hydrocortisone butyrate) 0.1% lotion (59 mL,
118 mL) 118 mLs/30 days
hydrocortisone butyrate 0.1% ointment (15
gm, 45 gm) 135 grams/30 days
Locoid Lipocream (hydrocortisone
butyrate) 0.1% hydrophilic lipo
cream (45 gm, 60 gm) 120 grams/30 days
Luxiq (betamethasone valerate) 0.12% foam (50 gm,
100 gm) 150 grams/30 days
Micort-HC (hydrocortisone acetate)
2.5% cream (28.4
gm) 120 grams/30 days
Olux (clobetasol propionate) 0.05% foam (50 gm,
100 gm) 200 grams/28 days
Olux-E (clobetasol propionate) 0.05% emulsion foam
(50 gm, 100 gm) 200 grams/28 days
Pandel (hydrocortisone probutate) 0.1% cream (80 gm) 160 grams/30 days
Psorcon, Diflorasone diacetate 0.05% cream (15 gm,
30 gm, 60 gm) 120 grams/30 days
Sernivo (betamethasone dipropionate) 0.05% spray (120 mL)120 mLs/30 days
Synalar (fluocinolone acetonide) 0.01% solution (60
mL, 90 mL) 120 mLs/30 days
Synalar (fluocinolone acetonide) 0.025% cream (15
gm, 60 gm, 120 gm) 120 grams/30 days
Synalar (fluocinolone acetonide) 0.025% ointment (15
gm, 60 gm, 120 gm) 120 grams/30 days
fluocinolone acetonide 0.01% cream (15 gm,
60 gm) 120 grams/30 days
clobetasol propionate 0.05% solution (25
mL, 50 mL) 200 mLs/28 days
Temovate (clobetasol propionate) 0.05% cream (15 gm,
30 gm, 45 gm, 60 gm)210 grams/28 days
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 48
Minnesota Medicaid Quantity Limit Program Criteria
Temovate (clobetasol propionate) 0.05% ointment (15
gm, 30 gm, 45 gm, 60
gm) 210 grams/28 days
clobetasol propionate 0.05% gel (15 gm, 30
gm, 60 gm) 210 grams/28 days
Temovate E (clobetasol propionate) 0.05% emollient
cream (15 gm, 30 gm,
45 gm, 60 gm) 210 grams/28 days
Texacort (hydrocortisone) 2.5 % solution (30
mL) 120 mLs/30 days
Topicort (desoximetasone) 0.05% cream (15 gm,
60 gm, 100 gm) 120 grams/30 days
Topicort (desoximetasone) 0.25% cream (15 gm,
60 gm, 100 gm) 120 grams/30 days
Topicort (desoximetasone) 0.05% gel (15 gm, 60
gm) 120 grams/30 days
Topicort (desoximetasone) 0.05% ointment (60
gm, 100 gm) 120 grams/30 days
Topicort (desoximetasone) 0.25% ointment (15
gm, 60 gm, 100 gm) 120 grams/30 days
Topicort (desoximetasone)0.25% spray (100 mL) 100 mLs/30 days
Trianex (triamcinolone acetonide) 0.05% ointment (430
gm) 430 grams/30 days
Ultravate (halobetasol propionate) 0.05% cream (15 gm,
50 gm) 200 grams/28 days
Ultravate (halobetasol propionate) 0.05% lotion (60 mL) 240 mLs/30 days
Ultravate (halobetasol propionate) 0.05% ointment (15
gm, 50 gm) 200 grams/28 days
betamethasone valerate 0.1% cream (15 gm,
45 gm) 135 grams/30 days
betamethasone valerate 0.1% lotion (60 mL) 120 mLs/30 days
betamethasone valerate 0.1% ointment (15
gm, 30 gm, 45 gm) 135 grams/30 days
Vanos (fluocinonide) 0.1% cream (30 gm,
60 gm, 120 gm) 240 grams/28 days
Topical Corticosteroids PS
AR1219_r0520Verdeso (desonide) 0.05% foam (100 gm)
100 grams/30 days
hydrocortisone valerate 0.2% ointment (15
gm, 45 gm, 60 gm) 120 grams/30 days
hydrocortisone valerate 0.2% cream (15 gm,
45 gm, 60 gm) 120 grams/30 days
Topical Doxepin PAQL **Topical Doxepin QL information is included in the individual program document
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 49
Minnesota Medicaid Quantity Limit Program Criteria
Topical Estrogen PS
AR1019_r0320
Alora (estradiol) 0.025 mg/day
transdermal system
8 patches/28 days
Alora (estradiol) 0.05 mg/day
transdermal system
8 patches/28 days
Alora (estradiol) 0.075 mg/day
transdermal system
8 patches/28 days
Alora (estradiol) 0.1 mg/day
transdermal system
8 patches/28 days
Climara (estradiol) 0.025 mg/day
transdermal system
4 patches/28 days
Climara (estradiol) 0.0375 mg/day
transdermal system
4 patches/28 days
Climara (estradiol) 0.05 mg/day
transdermal system
4 patches/28 days
Climara (estradiol) 0.06 mg/day
transdermal system
4 patches/28 days
Climara (estradiol) 0.075 mg/day
transdermal system
4 patches/28 days
Climara (estradiol) 0.1 mg/day
transdermal system
4 patches/28 days
Climara Pro (estradiol/levonorgestrel) 0.045 mg/0.015
mg/day transdermal
4 patches/28 days
CombiPatch (estradiol/norethindrone) 0.05 mg/0.14 mg/day
transdermal system
8 patches/28 days
CombiPatch (estradiol/norethindrone) 0.05 mg/0.25 mg/day
transdermal system
8 patches/28 days
Divigel (estradiol) 0.25 mg/packet gel 30 packets/30 days
Divigel (estradiol) 0.5 mg/packet gel 30 packets/30 days
Divigel (estradiol) 0.75 mg/packet gel 30 packets/30 days
Divigel (estradiol) 1.0 mg/packet gel 30 packets/30 days
Divigel (estradiol) 1.25 mg/packet gel 30 packets (37.5 g)/30 days
Elestrin (estradiol) 0.52 mg/pump with
gel
1 pump/30 days
Estring (estradiol) 2 mg vaginal ring (7.5
mcg/24 hour)
1 ring/90 days
Estrogel (estradiol) 50 g pump with gel
(1.25 g/dose)
1 pump/30 days
EvaMist (estradiol) 8.1 mL vial (1.53
mg/spray)
transdermal spray
5 vials/93 days
Femring (estradiol acetate) 0.05 mg/day vaginal
ring
1 ring/90 days
Quantity limits apply to Medicaid.
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 50
Minnesota Medicaid Quantity Limit Program Criteria
Femring (estradiol acetate) 0.10 mg/day vaginal
ring
1 ring/90 days
Imvexxy (estradiol) 4 mcg vaginal insert
(starter pack)
18 inserts/180 days
Imvexxy (estradiol) 4 mcg vaginal insert
(maintenance pack)
8 inserts/28 days
Imvexxy (estradiol) 10 mcg vaginal insert
(starter pack)
18 inserts/180 days
Imvexxy (estradiol) 10 mcg vaginal insert
(maintenance pack)
8 inserts/28 days
Menostar (estradiol) 1 mg (14 mcg/24
hour) patch
4 patches/28 days
Minivelle (estradiol) 0.025 mg/day
trasdermal system
8 patches/28 days
Minivelle (estradiol) 0.0375 mg/day
transdermal system
8 patches/28 days
Minivelle (estradiol) 0.05 mg/day
transdermal system
8 patches/28 days
Minivelle (estradiol) 0.075 mg/day
transdermal system
8 patches/28 days
Minivelle (estradiol) 0.1 mg/day
transdermal system
8 patches/28 days
Vivelle Dot (estradiol) 0.025 mg/day
transdermal system
8 patches/28 days
Topical Estrogen PS
AR1019_r0320
Vivelle Dot (estradiol) 0.0375 mg/day
transdermal system
8 patches/28 days
Vivelle Dot (estradiol) 0.05 mg/day
transdermal system
8 patches/28 days
Vivelle Dot (estradiol) 0.075 mg/day
transdermal system
8 patches/28 days
Vivelle Dot (estradiol) 0.1 mg/day
transdermal system
8 patches/28 days
Topical Lidocaine PAQL **Topical Lidocaine QL information is included in the individual program document
Triptan QL **Triptan QL information is included in the individual program document
Urinary Incontinence PS AR0819_r0320 Detrol (tolterodine)
a 1 mg tablet 2 tablets
Detrol (tolterodine)a 2 mg tablet 2 tablets
Detrol LA (tolterodine ER)a 2 mg extended-release
capsule 1 capsule
Detrol LA (tolterodine ER)a 4 mg extended-release
capsule 1 capsule
Quantity limits apply to Medicaid.
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 51
Minnesota Medicaid Quantity Limit Program Criteria
oxybutynin [Ditropan]a 5 mg tablets 4 tablets
oxybutynin [Ditropan]a 5 mg/5 mL syrup 20 mLs
Ditropan XL (oxybutynin ER)a 5 mg extended-release
tablet 1 tablet
Ditropan XL (oxybutynin ER)a 10 mg extended-release
tablet 2 tablets
Ditropan XL (oxybutynin ER)a 15 mg extended-release
tablet 2 tablets
Enablex (darifenacin ER)a 7.5 mg extended-release
tablet 1 tablet
Enablex (darifenacin ER)a 15 mg extended-release
tablet 1 tablet
Gelnique (oxybutynin) 1 gm (1.14 mL) gel
sachet (10% gel) 1 sachet
Gelnique (oxybutynin) 3% gel (28 mg/actuation,
90 actuations/pump)1 metered-dose pump / 30 days
Myrbetriq (mirabegron) 25 mg extended-release
tablet 1 tablet
Myrbetriq (mirabegron) 50 mg extended-release
tablet 1 tablet
Oxytrol (oxybutynin) 36 mg patch (delivers 3.9
mg per day) 8 patches per 28 days
trospium 20 mg tablet 2 tablets
trospium ER 60 mg extended-release
capsule 1 capsule
Toviaz (fesoterodine ER) 4 mg extended-release
tablet 1 tablet
Toviaz (fesoterodine ER) 8 mg extended-release
tablet 1 tablet
VESIcare (solifenacin)a 5 mg tablet 1 tablet
VESIcare (solifenacin)a 10 mg tablet 1 tablet
Vascepa PAQL **Vascepa QL information is included in the individual program document
VMAT2 Inhibitors (Formerly
Xenazine) PAQL **VMAT2 Inhibitors QL information is included in the individual program document
Wakix PAQL **Wakix QL information is included in the individual program document
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 52
Minnesota Medicaid Quantity Limit Program Criteria
Zavesca (Substrate
Reduction Therapy) PAQL **Zavesca QL information is included in the individual program document
MN_Medicaid_CS_QL_Programs_AR0320 © Copyright Prime Therapeutics LLC. 03/2020 All Rights Reserved 53